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Abstract
The assessment of health status has become of
paramount importance as efforts expand to explore the
impact of psychological factors and lifestyle variables on 
disease. The need to clearly assess the efficacy of
interventions designed to improve health and prevent health 
problems has provided an impetus for the development of 
assessment methodology in this area. There remains a need 
not only for vigorous research directed at the development 
of reliable and valid measures of health status, but also a 
critical need for the empirical validation of existing 
instruments. The complexity of variables influencing the 
health status of patients maintained on hemodialysis makes 
the assessment or quantification of health in this 
population exceedingly difficult. Although a variety of 
assessment procedures have been utilized clinically and in 
research, few investigations have directly assessed the 
psychometric properties of these measures. Of particular 
concern is the lack of demonstrated relations among various 
measures used to index health and important health outcomes 
for patients maintained on hemodialysis. The present study 
was designed to examine the concurrent and predictive 
validity of a number of measures of health status in a 
sample of hemodialysis patients. Subjects consisted of 131
adult outpatients with chronic renal failure who were 
receiving maintenance hemodialysis, and were followed over 
the course of one year. The measures of health status 
examined in the present investigation included biochemical 
analyses of blood urea nitrogen, potassium, phosphorous, 
and hematocrit; physician ratings of physical status; 
Wahler Physical Symptoms Inventory; staff ratings of 
functional status; subjective ratings of functional status; 
and subjective ratings of health. The relations among 
these measures of health status and other demographic and 
medical variables thought to impact health in this 
population were examined. Of primary importance were the 
relations among indices of health and subsequent medical 
utilization and survival. Results of the present 
investigation offer evidence for the concurrent validity of 
physician ratings of physical status, ratings of functional 
status, and the Wahler Physical Symptoms Inventory as 
measures of the construct of health status, and confirm 
previous findings which suggest that physician ratings are 




The decade of the 1970's witnessed phenomenal growth 
in behavioral science applications to medicine, broadly 
focused upon the etiology, treatment, management, and 
prevention of illness (Agras, 1982). Much of the credit 
for psychology's recent expansion in medicine has been 
attributed to the successful application of behavioral 
techniques with medical patients (Blanchard, 1982). 
Health-related research and clinical activities have 
rapidly expanded in recent years, in large part, due to the 
finding that individual habits or "lifestyle" variables may 
account for over half of the annual deaths in the United 
States (U.S. Department of Health and Human Services, 
1980). The escalating cost of health care has also 
provided a powerful economic impetus for the expansion of 
efforts directed at reducing medical utilization and 
altering lifestyle variables thought to contribute to 
health risk. For these reasons Cummings (1984) projected 
the area of health psychology to grow at a faster rate than 
any other aspect of clinical psychology. The rapidly 
developing fields of behavioral medicine and behavioral
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health share an emphasis on the development of technology 
directed at understanding health parameters as illustrated 
in their definitions. The Yale conference of the National 
Academy of Science adopted the following definition of 
behavioral medicine:
Behavioral medicine is the
interdisciplinary field concerned with 
the development and integration of the 
behavioral and biomedical science 
knowledge and techniques relevant to 
health and illness and the application 
of this knowledge and these techniques 
to prevention, diagnosis, treatment and 
rehabilitation (Schwartz & Weiss, 1977, 
p. 250).
Matarazzo (1980; 1982) further proposed a subcategory of
behavioral medicine that he felt more closely addressed the 
areas of health maintenance and prevention of illness which 
he labeled behavioral health. He defined behavioral health 
as:
an interdisciplinary field dedicated to 
promoting a philosophy of health that 
stresses individual responsibility in 
the application of behavioral and 
biomedical science knowledge and 
techniques to the maintenance of health 
and the prevention of illness and 
dysfunction by a variety of 
self-initiated individual or shared 
activities (Matarazzo, 1982, p.8).
In the area of health, much of the early work has 
focused upon intervention techniques rather than the
development of assessment procedures. Similarly, a general 
deficiency in assessment methodology has been noted to
characterize the behavioral medicine literature (Russo, 
Bird, & Masek, 1980). The assessment of health status has 
become of paramount importance as efforts expand to explore 
the impact of psychological factors and lifestyle variables 
on disease. Also, the need to clearly assess the efficacy 
of interventions designed to reduce disease incidence and 
affect the course of health problems has provided an 
impetus for the development of assessment methodology in 
this area. There remains a need not only for vigorous 
research directed at the development of reliable and valid 
measures of health status, but also a critical need for the 
empirical validation of existing instruments.
The assessment of health status will be reviewed, 
followed by an overview of chronic renal failure and 
dialysis procedures. This review is intended to provide a 
rationale for the proposed research objectives and 
methodology which will focus upon the assessment of health 
status in hemodialysis patients.
Assessment of Health Status
The available assessment methodology targeting health 
parameters continues to reflect the view that physical 
health and physical impairment are mirror images of one
another, that is, the presence of one is assumed to reflect 
the absence of the other. Although contemporary
definitions of health have generally rejected the notion 
that health is merely the absence of illness, no
satisfactory measure of positive health is yet available. 
Consequently, current measures of health status focus 
primarily upon the assessment of illness, i.e., the nature 
and degree of organic pathology which is present; or 
illness behavior, i.e., those behaviors thought to be 
associated with the presence of illness or disease such as 
symptom-reporting, functional limitations, and medical
utilization.
The medical examination, physician ratings of health, 
and physician diagnosed medical disorders are considered to 
be more objective indices of health status than the more 
frequently employed self-report measures of illness 
behavior such as subjective ratings of health, 
self-monitoring of health-related events, interviews, and 
questionnaires. Similarly, morbidity data are viewed as 
more objective if obtained through hospital records, as 
opposed to the collection of identical information from 
self-report measures. The medical examination often serves 
as the standard against which other assessment strategies 
are compared, because physicians remain the ultimate health 
status definers due to their training and expertise 
(Twaddle, 1974). In fact, researchers strongly caution, 
against the use of self-report indices of health as
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measures of true morbidity without verification of organic 
pathology through the use of the medical examination,
laboratory data, x-rays, etc. (Cleary, 1980; Marshall, 
Gregorio, & Walsh, 1982; Minter and Kimball, 1978). Sole 
reliance upon measures of illness behavior in the absence 
of medical validation is problematic, because a one-to-one 
correspondence is often falsely assumed between levels of 
illness behavior and the nature and degree of organic 
pathology present. Illness behavior can occur out of 
proportion to or even in the absence of an objective
disease state. Illness behavior per se may be merely 
reflecting characteristic ways of responding to symptoms or 
a reporting tendency which may affect both the report of 
symptoms and the response to symptoms rather than organic 
illness.
The actual use of a medical examination or physician 
ratings in the assessment of health status for research 
purposes is frequently severely limited due to practical
considerations such as cost. Additionally, the use of 
these "objective" measures as the only criteria for the 
validation of health status measures presents difficulties 
due to their heavy reliance upon clinical judgment and the 
often questionable reliability associated with many 
diagnostic instruments (Jones & Vischi, 1979; Twaddle,
1974).
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Subjective Ratings of Health
Subjective ratings of health are used extensively as 
an index of health status, and such measures are thought to 
assess a global, overall sense of well-being or tap the 
extent to which symptoms or disease limit functioning. 
Most commonly, subjects have been asked to rate their 
current health in terms of the following adjectives: 
excellent, good, fair, poor (e.g., Maddox, 1962; Otto,
1979) or to estimate their overall health on a 10-point 
scale ranging from very poor to excellent (e.g., Garrity, 
Marx, & Somes, 1978).
Despite their widespread use, particularly in 
epidemiological and gerontological research, self-ratings 
of health are generally considered to be a somewhat 
questionable substitute for objective health status 
measures or are viewed merely as an indicator of general 
well-being. In fact, self-ratings of general health have 
been found to be highly correlated with life satisfaction 
(Palmore & Luikart, 1972). However, the relation between 
self-assessment of health status and objective health 
status as measured by a comprehensive medical examination 
has been examined, and results have revealed a high degree 
of congruence between the two methods of assessment 
(Maddox, 1962; Maddox & Douglass, 1973). Otto (1979) 
similarly found that individuals reporting a high number of 
symptoms were significantly more likely to rate their
health as "fair" or "poor” as compared to those who 
reported few symptoms. Other health parameters such as 
frequency of illness episodes and number of health problems 
have been found to be significantly related to subjective 
ratings of health in an elderly community sample, although 
no consistent relation was found for an elderly 
institutionalized sample (Fillenbaum, 1979). Additionally, 
recent studies provide strong evidence for an association 
between self-rated health and mortality (e.g., Singer, 
Garfinkel, & Cohen, 1976). Mossey and Shapiro (1982) found 
a single measure of self-rated health to be a powerful 
predictor of subsequent mortality, independent of objective 
health status, in a large representative sample of elderly 
adults. A review of 39 studies of self-perceptions of 
health revealed such ratings to be both reliable and 
reproducible (Ware, Davies-Avery, & Donald, 1978).
Self-monitoring of Health-related Events
Self-monitoring of health-related behaviors has been 
utilized in the assessment of health status, both as a 
primary source of data and also as a memory aid to reduce 
recall error in subsequent health interviews. In a recent 
review of nineteen studies that employed health diaries, it 
was found that only seven used the diary as a primary 
source of health data with the remainder using it either as 
a reliability check on other measures of health or as a
memory device (Verbrugge, 1980).
Self-monitoring data has been obtained most often in a 
diary format, but journals and wall calendars have also 
been employed (e.g., Marcus, 1982; Norman, McFarlane, 
Streiner, & Neale, 1982; Ridgeway & Mathews, 1982). The 
variables frequently recorded in such monitoring devices 
include frequency and description of physical symptoms, 
subjective ratings of severity of symptoms, and action 
taken in response to symptoms such as medication usage or 
medical utilization. Self-monitoring data is usually 
collected on a set schedule such as in daily, weekly or 
monthly intervals, although novel sampling techniques have 
been adopted to increase compliance over long periods of 
data recording. For example, Norman et al. (1982) had 
subjects complete health diaries on three randomly selected 
days in each two-week period over the course of one year.
The fact that self-monitoring procedures rely less 
extensively upon retrospective reporting of health-related 
events makes them quite attractive as health status 
measures. Data from health diaries have been found to 
contain two to three times higher rates of reported 
symptoms than retrospective health interviews (Verbrugge,
1980). It is for this reason that self-monitoring formats 
have been widely utilized as memory aids to improve the 
reporting skills of respondents and reduce errors when 
answering questions in a subsequent interview. 
Additionally, self-monitoring provides a format for the
collection of data regarding mild or acute episodes of
illness, information that would not be reported to a 
physician nor accurately recalled in retrospective 
interviews. Thus, these procedures are thought to be a 
sensitive measure of a dimension of health that cannot be 
readily assessed through other health status measures.
The most noticeable limitation in the use of 
self-monitoring data is the finding that there is a decline 
in the completeness with which data is recorded over time. 
A significant drop of 5 to 25$ has been noted in the
reporting of symptoms in health diaries over a three-month 
period, and has been attributed to respondent fatigue 
(Mooney, 1962; Sudman & Lannom, 1978; Sudman, Wilson, &
Ferber, 1974). For this reason, self-monitoring of health
events has only been used infrequently in long-term 
longitudinal studies. Further research is needed aimed at 
improving long-term compliance.
Interview Formats
Structured interview formats have frequently been used 
to collect a wide variety of health-related information, 
and serve as a common method of data collection in health 
surveys (e.g., Garrity, Somes, & Marx, 1977; Murphy & 
Brown, 1980; Parker, You-long, Long-gen, De-yu, & Hinman, 
1982). Targets of assessment in either personal or 
telephone health interviews correspond to those of other
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measurement procedures and include frequency and 
description of physical symptoms, illness episodes, 
prevalence of diagnosed chronic disease, perceived severity 
of reported health problems, and resulting impairment in 
normal activities (e.g., days lost from work/school, time 
spent in bed).
The major limitation associated with the interview as 
a measure of health status is that the information obtained 
is of questionable accuracy. Health-related events have 
been found to be consistently underreported in such 
retrospective accounts (e.g., Madow, 1973; Meltzer, & 
Hockstim, 1970; Mooney, 1962; Moore, 1975). Bias in 
reporting has been linked primarily to faulty recall and 
has been found to be related to length of the time interval 
between the event and the interview. In addition, the 
perceived severity of a health event has been shown to 
affect recall, with minor symptoms or illnesses being 
recalled more poorly (Cannell, Marquis, & Laurent, 1977). 
It is for this reason that self-monitoring procedures such 
as the health diary have been used to improve the accuracy 
of information provided in health interviews.
Symptom Inventories
A number of inventories are currently available that 
focus upon physical symptoms, illness or disease. Symptom 
checklists are self-report inventories that provide
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information related to physical health. Despite the 
limitations inherent in self-report methods of assessment, 
symptom inventories provide a large amount of data rapidly, 
and therefore can serve effectively both as a screening 
device and as a primary source of information regarding 
health status. Procedurally, such instruments require 
little professional time expenditure due to their ease of 
administration and simplicity of interpretation.
The Cornell Medical Index (Brodman, Erdman, Lorge, & 
Wolff, 1949; 1952; Brodman, Erdman, & Wolff, 1949) is one
of the most widely utilized symptom checklists. It is 
often employed by physicians as an adjunct to the medical 
examination and has been used in research as an index of 
symptomatology. The Cornell Medical Index is a 195 item 
true-false inventory that provides information regarding 
physical symptoms involving various organ systems, as well 
as vague physical complaints. Additional information is 
gained regarding past medical problems, family history of
disease, and affective complaints. In fact, over 25# of
items address psychological symptoms such as moods,
feelings, and behavior patterns. Although data supporting 
the validity of this index is sparse, the Cornell Medical 
Index has been compared to an unstructured medical history 
interview and was found to be more inclusive in terms of 
symptom coverage (Brodman et al., 1949).
The Wahler Physical Symptoms Inventory (Wahler, 1968) 
is a 42 item symptom checklist designed to assess the
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degree and specificity of somatic complaints. Each 
physical symptom is rated on a 6-point scale with regard to 
frequency ranging from 0 (almost never) to 5 (nearly every 
day). This inventory samples exclusively somatic symptoms 
or complaints and includes no items related to emotional 
and mood symptoms such as worry, anxiety or depression. 
Items contained in the scale were derived from the Cornell 
Medical Index (Brodman et al.,1949), MMPI Hypochondriasis 
Scale (Hathaway & McKinley, 1942), and clinician generated 
items. Data are available regarding the internal
consistency and test-retest reliability of this instrument. 
Internal consistency estimates based on the KR-20, an index 
of internal consistency based on scores from a single 
administration of an instrument, were found to range from 
.85 to .94 (M = .91) over several samples including
university students, rehabilitation patients, psychiatric 
patients, and a sample of patients seeking disability 
compensation. Test-retest reliability has been assessed 
over varying time intervals in both normal and clinical 
samples. Coefficients of stability ranged from .69 to .94 
(M = .81) over intervals of one day to one week, and
declined to .45 to .84 (M = .67) over intervals from one to 
thirteen weeks. The Wahler Physical Symptoms Inventory was 
found to discriminate significantly between groups of 
subjects with different levels of expected symptomatology 
or different incentives for reporting and emphasizing 
somatic complaints such as healthy college students,
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disability claimants, rehabilitation patients, and
psychiatric patients (Wahler, 1983). The primary
advantages related to the use of this inventory as a 
measure of health status include the provision of a 
frequency rating of complaints and an exclusive focus on 
physical (somatic) symptoms.
Another self-report checklist, The Seriousness of 
Illness Rating Scale (Wyler, Masuda, & Holmes, 1968; 1970) 
has been used primarily for research purposes. It contains 
126 commonly recognized health problems (e.g., peptic 
ulcer, fainting, leukemia, chest pain, dandruff, irregular 
heart beat, etc.), all of which have a general severity 
weight that reflects "seriousness". Weights were
determined by having 117 physicians and 141 non-physicians 
rate each health problem with regard to variables such as 
threat to life, prognosis, degree of disability, and 
discomfort. The Seriousness of Illness Rating Scale has
been found to be significantly related to other measures of
severity or seriousness of illness including subjective 
ratings of seriousness of health problems, number of days 
each health problem was experienced, number of days on 
which each health problem prevented the pursuit of normal 
activities, and ratings of overall health status (Garrity 
et al., 1978). This scale has been frequently employed in 
studies addressing the relation between stress and illness 
(e.g., Cooley, Miller, Keesey, Levenspiel, & Sisson, 1979; 
Garrity et al., 1977; 1978).
A symptom checklist that has been employed as a 
measure of health status primarily in health surveys is the 
Health Insurance Study Index (HIS; United States National 
Center for Health Statistics, 1957). The HIS is a 
checklist of chronic conditions including dental problems, 
stomach trouble, nerve trouble, skin problems, ear trouble, 
eye trouble not relieved by glasses, palsy, stroke, 
arthritis or rheumatism, and heart and circulation 
problems. Inconsistent findings have been reported
regarding the reliability of this scale, yet it has been 
used extensively to assess the health status of elderly 
populations residing in the community and in institutions 
(Chappell, 1981). A number of similar, but abbreviated 
symptom checklists have been constructed primarily for 
research purposes (e.g., Billings & Moos, 1981; Miller, 
Ingram, & Davidson, 1976; Murphy & Brown, 1980; Otto, 
1979). Little data is available regarding the reliability 
and validity of these indices making comparisons across 
studies problematic.
Functional Status Measures
The assessment of functional status involves various 
attempts to quantify the extent of functional impairment 
resulting from health problems. An individual's ability to 
perform the activities required of daily living are 
generally targeted for assessment and include such
15
categories of behavior as: mobility (e.g., Are you able to 
drive a car?), self-care (e.g., Are you able to bathe 
without assistance?), physical activities (e.g., Do you 
have trouble getting up and down stairs?), and role 
activities (e.g., Are you able to perform light
housework?). Although the majority of the general
population will score perfectly on a specific measure of 
functional status despite the presence of various symptoms, 
the assessment of funtional ability becomes critical in 
attempts to measure health status in both chronic illness 
populations and the elderly. For these groups, a 
definition of health that merely encompasses the absence of 
symptoms or illness is meaningless. Therefore, a more 
important aspect of health is the absence of "debilitating" 
illness (Maddox & Douglas, 1973).
One of the most frequently used self-report measures 
of functional status is the Activities of Daily Living
(Katz, Akpom, Papsidero, & Weiss, 1973). This scale 
primarily measures activities associated with self-care, 
that is, dressing, feeding, bathing, transfer, toileting, 
and continence. It is easily administered and scored, with 
the overall score reflecting level of dependency upon 
others in carrying out self-care activities. Similar
instruments that sample a variety of daily living tasks 
(e.g., financial matters, getting in and out of bed ) 
include the Index of Living Skills (Shanas, Townsend, 
Wedderburn, Friis, Milhoj, & Stehouwer, 1968); The Sickness
Impact Profile (Gilson, Gilson, Bergner, Bobbit, Kressel, 
Pollard, & Vesselago, 1975); and Shanas* Index of 
Disability (Shanas et al., 1968). The Functional 
Limitations Battery (Patrick, Bush, & Chen, 1973) assesses 
various categories of specific functioning, but 
additionally the status of each limitation is broken down 
into chronic limitations, those present for more than three 
months, and acute limitations, those present for three 
months or less. Another functional status measure, the 
Physical Capacities Battery (Hulka & Cassel, 1973) has 
incorporated a 21-item checklist of health problems for 
purposes of identifying the reason for each limitation 
endorsed.
Several health status questionnaires have combined the 
assessment of functional ability with measures of symptoms 
in an effort to provide a more sensitive measure of health 
status. It is thought that despite a given level of 
functional ability, the presence of symptoms can further 
impact upon health status. Adding a measure of symptoms 
also allows one to discriminate between individuals who are 
without functional limitations, but who are in obviously 
different states of health. The Health Status
Questionnaire elicits information on a wide variety of 
chronic conditions and specific symptoms, and also assesses 
degree of disability in working, eating, dressing, and 
mobility. It has been found to be reliable and valid in 
comparison with medical records (Meltzer & Hockstim, 1970).
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Similarly, the Index of Well-Being (Kaplan, Bush, & Berry, 
1976) assesses both the ability to perform activities 
related to mobility, social activity, self-care, and 
physical activity, and takes into account the presence of 
symptoms.
Although functional status has been primarily 
determined through the use of self-report inventories which 
target specific behaviors, global ratings of functional 
limitations have also been employed in research. For 
example, Naliboff, Cohen, and Yellen (1982) used a 4-point 
subjective rating scale to assess perceived functional 
limitations in a migraine headache sample. The
self-ratings were found to correlate .53 with spouse 
ratings of limitations, and moderate correlations were also 
found between self-ratings and physical therapist rated 
indices of physical performance (e.g., strength, range of 
motion). Ratings of functional status have also been 
completed by various staff members in a hemodialysis unit 
such as physicians, nurses, and social workers in an effort 
to obtain a more objective measure of physical limitations 
(e.g., Steidl, Finkelstein, Wexler, Feigenbaum, Kitse, 
Kliger, & Quinlan, 1980). Both self-report inventories and 
subjective ratings of functional status assess only 
perceived limitations, not actual performance. Therefore, 
caution should be used in the interpretation of data 
resulting from subjective measures of functional status 




Physician ratings of various health parameters are 
frequently employed to quantify findings resulting from a 
medical examination. Although global overall ratings of 
health are most often used (e.g., Maddox & Douglas, 1973)> 
highly structured formats that provide a broad range of 
information are available. The Karnofsky Performance 
Status Scale (Karnofsky, 1949) is a physician-rated 
functional status measure that has been widely used in its 
original form since its introduction in 1949. It is an 
11-point rating scale that assesses level of functioning in 
three important areas: self-care, level of activity, and
ability to work. Despite the long history of its use, 
reliability and validity data have only become available in 
the past few years. Recent studies examining the
reliability and validity of this instrument reveal 
discrepant findings. Hutchinson, Boyd, and Feinstein
(1980) found the Karnofsky Performance Status Scale to 
possess low interrater reliability when employed with 
emergency room patients and chronic hemodialysis patients. 
Additionally, low correlations were noted between physician 
ratings and patient self-ratings of functional status. 
However, a large sample of cancer patients were evaluated 
with this instrument, and it was found to be both reliable
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and valid when employed by trained physicians using 
behaviorally based guidelines (Schag, Heinrich, & Gonz, 
1984).
A highly structured "objective" health status index
was developed by Mossey and Shapiro (1982) and used in a
study of health in an elderly population. The index
contains a physician designated ICDA-8 three digit 
diagnostic code for each outpatient visit and
hospitalization. The ICDA diagnoses were also classified 
by the physician according to the following health
parameters: expected duration of illness defined as acute
or chronic; degree of seriousness of illness episode rated
on a 5-point scale; and the presence of an associated risk 
to recovery. Extensive reliability, predictive validity, 
and construct validity data were presented to support the 
use of this index.
Medical Utilization
The rate of medical utilization is an aspect of
illness behavior frequently employed as an index of health 
status. The rate of health care utilization is generally 
defined as the frequency of outpatient physician contacts, 
number of hospitalizations, number of hospital days, and 
number of surgeries. Data suggests that only the more 
severe health problems are brought to the attention of a 
physician, indicating that medical utilization may be a
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relatively insensitive measure of overall health status in 
the general population (Norman et al., 1982). However, in 
more severely ill populations such as various chronic 
illness groups, the frequency of medical utilization is 
viewed as reflecting important changes in disease status 
(Wilson & Drury, 1984).
Although such data are frequently ascertained through 
various self-report formats, the information is considered 
to be most objective if obtained from medical/hospital 
records (e.g., Pope, 1982), insurance claim forms (e.g., 
Mossey & Shapiro, 1982) or a brief encounter form filled 
out by the physician at the time of an outpatient visit 
(e.g., McFarlane, Norman, Streiner, Roy, & Scott, 1980; 
Norman et al. , 1982). These sources yield not only data
related to the frequency of utilization of health care 
services, but also provide information regarding presenting 
complaints, medical diagnosis, and prognostic variables. 
If information is obtained through self-report formats 
only, medical utilization as an indicator of health status 
may be confounded with "care-seeking" behavior. A large 
percentage of patients in the general population have been 
found to present to physicians with no demonstrable organic 
illness, and many instead evidence primarily psychological 
problems (Kaufman, 1959; Lipowski, 1967; Nigro, 1970). 
Further, those individuals in whom physicians can find no 
organic illness frequently demonstrate a high rate of 
medical utilization (Harrington, 1978). Therefore, when
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medical utilization is employed as an index of true 
morbidity in a population, verification of organic 
pathology through physician diagnosis, laboratory tests and 
the like is essential.
Mortality
In addition to morbidity reports, mortality has 
frequently been used as an index of health. Information 
related to occurrence of death, date of death, and cause of 
death have been obtained through hospital insurance claim 
forms, hospital discharge summaries for those persons who 
die in the hospital, and death certificates. The 
widespread use of mortality statistics in determining the 
health of populations is due primarily to the availability 
of such information, and because such data is inexpensive 
to access (Chambers, 1982). However, limitations exist in 
the use of such routinely reported data due to its often 
questionable accuracy (Hunt, McKenna, McEwen, Backett, 
Williams, & Papp, 1980). Of particular concern is the lack 
of thoroughness frequently used in completing death 
certificates. Similarly, difficulties are encountered in 
establishing the correct cause of death or diagnosis in 
hospitalized patients. The problems associated with 
routinely reported mortality statistics together with a 
growing interest in collecting data relevant to other 




There are problems associated with all currently 
available measures of health status, and no single measure 
appears to be superior (Brantley & Bruce, 1986). 
Therefore, an approach that employs the assessment of 
various parameters of health in determining physical status 
appears warranted at present. An example of such an 
approach is the Arthritis Impact Measurement Scales 
(Meenan, Gertman, & Mason, 1980). This instrument is 
composed of a patient self-administered scale and a 
physician supplement rating scale. The self-administered 
scale contains a detailed assessment of a number of areas 
including functional status, pain, medication usage, and 
psychological functioning. A subjective rating of health 
status and arthritis status are also included. The 
physician supplement is composed of a rating of disease 
activity, and a physician assessed functional status rating 
scale. A substantial amount of data regarding the 
reliability and validity of this instrument are available 




Chronic, intermittent or maintenance dialysis refers 
to a treatment modality that is performed on a regular, 
continuing basis to maintain life in individuals with 
irreversible renal failure or end stage renal disease. 
Approximately 56,000 Americans suffering from chronic renal 
failure were being kept alive in 1981 by either 
extracorporeal hemodialysis or peritoneal dialysis. 
Annually this treatment costs in excess of 1.2 billion 
dollars in governmental expenditures (Friedman, 1983).
Chronic renal failure and the resulting changes in 
physiological functioning will be discussed. Dialysis 
procedures will also be reviewed, as well as the associated 
medical complications and data related to survival.
Chronic Renal Failure
In healthy individuals, the kidneys sustain life by 
performing a number of critical functions which include the 
filtration of the body’s waste materials; the regulation of 
the volume and chemical composition of the blood; the 
production of erythropoietin which regulates the 
circulating hemoglobin through stimulation of the bone 
marrow; and assistance in the regulation of blood pressure 
and extracellular fluid volume through the secretion of the
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hormone, renin.
Chronic renal failure is a functional term that refers 
to a progressive and generally irreversible decline in 
kidney function. The etiology is varied, and a large 
number of diseases can result in chronic renal failure. 
Kokko (1983) reviewed data related to the causes of chronic 
renal failure in North American patients on maintenance 
dialysis. Glomerulonephritis, a heterogenous group of 
glomerular disorders, was noted to be the causal factor for 
chronic renal failure in 41.6$ of the patients. 
Cardiovascular disease and hypertension were the 
etiological factors in 13.5$; urinary tract disease 10.5$; 
unknown 8.4$; congenital abnormalities 7.6$; diabetes 7.2$; 
kidney infections 6.1$; and other known factors 5.1$.
Three stages of chronic renal failure have been 
described and include diminished renal reserve, renal 
insufficiency, and uremia (Hekelman & Ostendarp, 1979). 
Diminished renal reserve reflects reduced renal function, 
but the excretory and regulatory functions of the kidney 
are still preserved. Renal insufficiency refers to the 
accumulation of metabolic wastes in the serum and 
concomitant elevations in blood urea nitrogen (BUN) and 
serum creatinine that occurs when at least half of normal 
kidney function is lost. Uremia is a syndrome resulting 
from the inability of the kidneys to maintain homeostasis 
and generally occurs when overall renal function is less 
than 20 to 25$ of normal. Most organ systems continue to
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function normally during the early phases of advancing 
renal failure, but the uremic syndrome is characterized by 
derangement of function of many systems of the body. 
Treatment alternatives include conservative medical 
management until renal function decreases to 10 to 15$ of 
normal. At that stage, maintenance dialysis or renal 
transplantation are required to sustain life.
Uremic Syndrome
The myriad of clinical symptoms and physiological 
changes that result from advanced chronic renal failure are 
referred to as the uremic syndrome. Toxic substances in 
the body fluid which are normally excreted in the urine 
have been implicated as causal factors of the uremic 
syndrome. The consistent finding that azotemic patients 
improve symptomatically after the initiation of 
hemodialysis has supported a search for "uremic toxins" 
(Bergstrom & Furst, 1983). Initially, researchers thought 
that uremic symptoms were produced by high concentrations 
of urea, a by-product of protein metabolism that is 
eliminated primarily by the kidneys. But strong evidence 
indicates that all of the clinical features of chronic 
renal failure are not due solely to the accumulation of 
urea (Blachley & Knochel, 1981). A number of substances 
have been identified in elevated concentrations in the 
serum of uremic patients, but to date all of the clinical
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manifestations of the uremic syndrome cannot be explained 
by the accumulation of known compounds (Bergstrom & Furst, 
1983).
The various symptoms of the uremic syndrome and the 
associated abnormalities in physiological functioning will 
be briefly reviewed.
Cardiovascular system. The most frequently occurring 
cardiovascular disorder associated with chronic renal 
failure is hypertension. Two causal factors have been 
identified in uremic patients and include the inability of 
the kidneys to excrete sodium and water resulting in 
hypervolemia, and derangement in the renin-angiotensin 
system resulting in the production of large quantities of 
renin. Approximately 70% of the hypertension in uremia due 
to fluid and sodium overload can be controlled with dietary 
reductions in sodium and fluid intake and/or fluid removal 
by dialysis (Delano, 1983). However, hypertension
resulting from increased renin production may require 
administration of antihypertensive medication or, in some 
cases, bilateral nephrectomy to remove the source of renin 
production (Onesti, Kim, Greco, del Guercio, Fernandes, & 
Swartz, 1975).
Hyperkalemia occurs in uremic patients due to the 
kidneys' diminished capacity to excrete potassium. In 
excess of 90% of the daily intake of potassium is excreted 
through the kidneys in healthy individuals. Patients with 
chronic renal failure are placed on a potassium restricted
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diet, but failure to follow the prescribed dietary regimen 
can result in hyperkalemia. Other contributing factors 
include acidosis, ingestion of potassium in medications, 
blood transfusions, and bleeding. Hyperkalemia can produce 
ventricular tachycardia, fibrillation, and cardiac arrest, 
and has been termed the "silent killer" in renal disease, 
because such complications can occur with little warning.
Pericarditis, an inflammation of the pericardial sac 
occurs in approximately 25% of chronic renal failure 
patients (Comty, Wathen, & Shapiro, 1976). Although the 
etiology is unknown, uremic toxins are thought to inflame 
and irritate the pericardium. Treatment generally focuses 
upon frequent dialysis until the condition improves
(Silverberg, Oreopoulos, Wise, Uden, Meindok, Jones, 
Rapaport, & de Veber, 1977). Complications include 
hemorrhagic effusion and cardiac tamponade.
Congestive heart failure is generally the first 
clinical manifestation of depressed cardiac function in 
chronic renal failure. Symptoms include dizziness, changes 
in mental status, and fatigue with minimum exertion.
Although due to low cardiac output, such symptomatology is 
frequently attributed to depression, atherosclerotic 
disease, metabolic abnormalities or old age (Forst &
O'Rourke, 1981). Contributing factors include
hypertension, retention of sodium and water, and severe 
anemia.
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Hematological system. A number of hematological
abnormalities are associated with chronic renal failure, 
but the most universal is anemia. When the hematocrit 
falls below 20 - 25%, a number of symptoms generally occur 
such as pallor, dyspnea, fatigue or tachycardia. The
etiology of anemia secondary to chronic renal failure is 
multifactorial and includes inadequate production of 
erythropoietin; shortened red blood cell survival due to 
elevated uremic toxins; blood loss due to mucosal
irritation; blood loss from iatrogenic blood testing; and 
loss of blood in hemodialysis tubing and coils (Delano, 
1983). Hemodialysis will decrease the level of uremic 
toxins in the serum and increase the lifespan of red blood 
cells toward normal. However, treatment of severe anemia 
may also include blood transfusions. Androgen therapy has 
been used with some success to increase the hematocrit in 
these patients (Raga, Kramer, & Rosenbaum, 1977). Iron or 
folate supplements are administered if needed to correct 
deficiencies.
Platelet abnormalities are commonly observed in
chronic renal failure and include a decrease in the number
of platelets and a defect in the quality of platelets
(Kukko, 1983). Elevated uremic toxins are thought to
increase peripheral destruction of platelets and result in
prolonged bleeding time, and a decrease in platelet
adhesiveness and platelet aggregation. A hemorrhagic 
tendency manifested by excessive bleeding or bruising after
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trauma is frequently observed. Dialysis can often correct 
these abnormalities.
Chronic renal failure is also associated with an 
increased susceptibility to infections which may be due to 
a number of factors (Montgomerie, Kalmanson, & Guze, 1968; 
Wilson, Kilpatrick, & Talmadi, 1965). Typically, there are 
abnormal responses to mitogenic stimulation. This
abnormality may be due to uremic toxins, because lymphocyte 
function is found to return to nearly normal following 
vigorous dialysis (Kukko, 1983). The neutrophil count is 
generally normal in these patients, however, a transient 
decrease is found to occur following the onset of 
hemodialysis. Patients generally remain asymptomatic, and 
the count returns to normal within one to two hours. 
Additionally, the ability of leukocytes to phagocytize 
bacteria is decreased in uremic patients. Frequent 
exposure of dialysis patients to bacterial and viral agents 
contributes to the increased frequency of infections. 
Also, of concern is the high incidence of hepatitis in 
these patients thought to be due to increased exposure, as 
well as multiple blood transfusions (Galbreath, Portmann, 
Eddelston, Williams, & Gower, 1975).
Gastrointestinal system. Anorexia, nausea, vomiting, 
and hiccup are among the earliest clinical manifestations 
of uremia. Anorexia and vomiting are of particular 
concern, in that such symptoms can result in fluid and 
electrolyte imbalance and contribute to weight loss.
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Generally, these symptoms abate after the initiation of 
dialysis.
Other symptoms common in advanced uremia include the 
smell of urine and ammonia to the breath, gum ulceration, 
metallic taste, and stomatitis (Brundage, 1976). Such 
symptoms are thought to be due to the conversion of urea in 
the saliva to ammonia. Additional gastrointestinal
problems such as glossitis, gastritis, and enterocolitis 
result primarily from inflammation and ulceration of the 
gastrointestinal mucosa due to elevated uremic toxins.
Constipation is also a frequent complaint associated 
with chronic renal failure. This symptom results from the 
administration of aluminum hydroxide gels which are given 
as phosphate binders to treat osteodystrophy. 
Consequently, concomitant administration of a stool 
softener is frequently required (Stone, 1977).
Integument. In advanced chronic renal failure, the 
skin has a characteristic discoloration of a grayish-bronze 
color due to retained pigments which are normally excreted 
by the kidneys. As noted previously, pallor results from 
anemia. The skin is usually dry and scaly due to a 
decrease in the activity of oil glands and a decrease in 
the size of sweat glands. Pruritus (itching) is a frequent 
complaint in uremic patients and can be quite severe. 
Usually there are no dermatologic findings, and to date no 
single causative factor has been identified (Kukko, 1983)• 
Therefore, treatment is symptomatic and has included oral
antihistamine and sedative administration, dietary protein 
restriction, increased frequency of dialysis sessions, and 
exposure to ultraviolet light (Lazarus, 1981). Due to the 
platelet abnormalities observed in uremia and increased 
fragility of capillaries, purpura and ecchymoses frequently 
result from even minor blows to the skin.
Neurological abnormalities. The neurological
manifestations of uremia are numerous, and patients may 
evidence abnormalities in central and peripheral nervous 
system function (Kukko, 1983). Cerebral impairment may 
result from direct toxicity of the central nervous system 
producing symptoms of headache, lassitude, insomnia, 
drowsiness, stupor, coma, and convulsions. Cognitive 
functioning may be affected as evidenced by an inability to 
concentrate, shortened attention span, memory deficits, and 
confusion. Behavioral and affective changes may include 
irritability, withdrawal, apathy, lack of interest in the 
environment, decreased or absent libido, and depression, as 
well as psychotic behavior including delusional thinking.
Chronic renal failure is also commonly associated with 
a slowing of peripheral nerve conduction leading to 
peripheral neuropathy. The pathophysiology in most
patients is not well understood. Peripheral neuropathy 
produces a number of clinical symptoms including painful 
paresthesias of the extremities, loss of deep tendon 
reflexes, muscular weakness, and occasionally sensory 
deficits. The most common motor nerve abnormality observed
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in these patients is bilateral food drop (Lancaster & 
Pierce, 1979). The "restless legs syndrome" is one of the 
earliest signs of peripheral neuropathy and includes 
painful parasthesias, cramping, and itching of the lower 
extremities (Callahan, 1966; Teschan & Ginn, 1976). The 
"burning feet syndrome" is frequently observed and is 
characterized by bilateral burning sensations of the feet, 
as well as painful paresthesias. The symptoms of 
neuropathy have been improved by the use of large surface 
membrane dialyzers and by extending the period of dialysis.
Metabolic abnormalities. Uremic patients evidence a 
number of metabolic abnormalities which include a
derangement in protein metabolism, carbohydrate 
intolerance, and hyperlipidemia.
Protein is broken down into amino acids during 
digestion. Urea and nitrogen are waste products resulting 
from amino acid metabolism. In healthy individuals, urea 
and nitrogen are eliminated by the kidneys and excreted in 
the urine. However, in chronic renal failure, these
protein byproducts accumulate in the blood and are 
reflected in a rise in BUN (blood urea nitrogen). As noted 
previously, elevated concentrations of urea are
responsible, in part, for the development of the uremic 
syndrome. By restricting the amount of protein ingested, 
the concentration of urea and nitrogen in the serum can be 
reduced. Therefore, uremic patients are frequently placed 
on low-protein diets.
The impaired glucose tolerance associated with chronic 
renal failure is referred to as "uremic pseudodiabetes 
mellitis" (DeFronzo, Tobin, Rowey, Sapir, Kramer, & Andres, 
1974). Insulin is filtered and metabolized by the kidneys 
in healthy individuals. But in chronic renal failure,
slowed insulin degradation by the kidneys leads to an 
increased half-life and elevated serum levels. Although 
increased levels of insulin are available, the insulin is 
not effectively utilized due to peripheral resistance. The 
decreased sensitivity of peripheral tissues to insulin
found in these patients is thought to be due to an enzyme 
abnormality associated with uremia (Lancaster & Pierce, 
1979). There does not appear to be a defect in the
production of insulin in response to glucose in uremic 
patients, but a delay in production has been found to 
occur. Maintenance dialysis appears to improve insulin and 
glucose metabolism, but does not return them to normal
(DeFronzo et al., 1974).
•7
Abnormalities in lipid metabolism associated with 
chronic renal failure include elevated triglyceride
concentrations and near normal or slightly elevated plasma 
cholesterol levels. Etiologic factors in hyper­
triglyceridemia are not well understood, but defects
specific to triglyceride removal appear to be involved
(e.g.,, Ibels, Reardon, & Nestel, 1976). The serum level 
of triglycerides does not decrease after the initiation of 
dialysis. In fact, chronic dialysis patients evidence a
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higher incidence of this metabolic abnormality than 
nondialyzed uremic patients (Lancaster & Pierce, 1979). 
Hyperlipidemia has been linked to atherosclerosis, and many 
dialysis patients develop this disease.
Skeletal System. The skeletal changes commonly
associated with uremia are collectively referred to as 
renal osteodystrophy. They include osteitis fibrosa,
osteomalacia, osteoporosis, and osteosclerosis which are 
manifested by such symptoms as bone pain, fractures, and 
periarticular calcifications. Some degree of bone disease 
is almost universal in renal failure (Kukko, 1983).
Hyperparathyroidism, alterations in vitamin D metabolism, 
and chronic low grade metabolic acidosis are causal factors 
in renal osteodystrophy, and together result in the
demineralization of the skeleton. Prevention and treatment 
of renal osteodystrophy includes lowering of serum 
phosphate with the administration of phosphate binding 
mechanisms; administration of vitamin D supplements to 
increase calcium levels; and, in cases of severe bone 
disease, parathyroidectomy may be indicated.
Endocrine Abnormalities. Among the associated
endocrine problems in chronic renal failure are 
abnormalities in gonadal function. Advanced renal failure 
commonly results in infertility, amenorrhea, cessation of 
ovulation, decreased libido, and impotence (Bailey, 1977). 
Research regarding the etiology of sexual dysfunction in 
uremic patients has implicated psychological, as well as
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pathophysiological factors (Bommer, Tschoppe, Ritz, & 
Andrassy, 1976). Maintenance dialysis is associated with 
the resumption of ovulation and menstruation, and some 
improvement in sex drive. But renal transplantation often 
leads to significant improvement in gonadal function (e.g., 
Holdsworth, Dekretser, & Atkins, 1978).
In summary, chronic renal failure affects the 
functioning of nearly all major systems of the body. 
Maintenance dialysis is able to improve or correct some of 
the abnormalities associated with the uremic syndrome, but 
other symptoms and derangements persist.
Dialysis Procedures
Dialysis involves the removal of accumulated metabolic 
waste products from the blood, and the restoration of 
water, electrolyte, and acid-base balance. This process 
can be achieved either through the use of synthetic 
membranes (extracorporeal hemodialysis) or the peritoneal 
membrane within the abdominal cavity (peritoneal dialysis). 
Both procedures rely on diffusion down a concentration 
gradient and across a semipermeable membrane which 
selectively permits the transfer of particles according to 
their molecular weight. In this way, adjustments in 
concentration and content of blood solutes are achieved.
Extracorporeal hemodialysis requires access to the 
circulatory system which involves either an internal or
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external device which shunts the blood between an artery 
and vein. The blood is passed through an "artificial 
kidney" which contains a semipermeable membrane and 
dialyzing fluid similar in composition to normal plasma. 
Fluid and wastes are removed from the serum and returned to 
the patient through a vein. Factors such as degree of 
residual renal function, body size, dietary intake, and 
clinical status determine the duration of dialysis, type 
and size of the dialyzer, and rate of blood flow. Stable 
patients are typically dialyzed for three to four hours per 
treatment, and treatment sessions are scheduled usually 
three times a week (Lazarus, 1981).
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Peritoneal dialysis requires access to the peritoneal 
space where a catheter is inserted, and dialysis fluid is 
introduced and then drained. It is a simpler procedure 
than hemodialysis and requires less specialized equipment. 
Peritoneal dialysis is occasionally employed in patients 
with chronic renal failure who develop complications in 
access availability and complications due to 
heparinization. Clearly, the major disadvantages
associated with peritoneal dialysis are the time required 
for treatment and increased risk of infection.
Maintenance dialysis can be performed in an outpatient 
clinic setting staffed by trained nurses and technicians or 
at home. Even though self-dialysis at home is an efficient 
way to decrease the cost of long-term dialysis and is 
preferable to some patients, the majority of patients
receive treatment at outpatient centers (Blagg & Scribner, 
1980; Rennie, 1978). In fact,. the 1970's witnessed a 
sustained decrease in the proportion of all hemodialysis 
patients treated at home from a reported 39.856 in 1972 to 
12.9$ in 1977. The decline in number of patients on 
dialysis at home has been attributed to physician bias 
rather than a clinical failure of this mode of therapy 
(Friedman, Delano, & Butt, 1978). Other factors which 
mitigate against home dialysis include severe medical 
complications, the lack of an adequate dialysis partner or 
appropriate home setting, and current federal reimbursement 
practices (Wauters, Hunziker, & Brunner, 1983). In-center 
dialysis can be conducted by trained staff or by the 
patient. In self-care dialysis, the patient has
responsibility for managing his own therapeutic regimen, 
and staff are available for assistance as needed.
Dialysis Treatment Regimen. In addition to regularly 
scheduled dialysis sessions, the treatment regimen for 
these patients includes replacement therapy and dietary 
restrictions. Ascorbic acid, folic acid, and B-complex 
vitamins are removed to a significant extent during 
dialysis due to their size and water solubility. In order 
to prevent depletion, multiple vitamins and folate are 
routinely prescribed. Aluminum hydroxide is administered 
to decrease serum phosphorous levels. Intake of vitamin D 
may be recommended to decrease hypocalcemia and possibly 
prevent or reverse secondary hyperparathyroidism. Iron
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supplements and blood transfusions are used in the 
treatment of anemia.
Dietary restrictions are extensive and of critical 
importance in the dialysis treatment regimen. Fluid 
control helps to decrease hypertension and/or edema. 
Phosphorous intake is restricted in order to augment the 
phosphorous-binding gels and decrease serum levels. Sodium 
contributes to hypertension, as well as hypotension, and 
excessive thirst, and intake is closely controlled. 
Ingestion of potassium through diet or medications is 
restricted to prevent hyperkalemia. An adequate level of 
protein is needed to maintain positive nitrogen balance, 
but intake is controlled in order to keep blood urea 
nitrogen (BUN) levels low.
Adequate Treatment. The adequate management of
patients with chronic renal failure on maintenance dialysis 
remains a significant challenge. A well delineated and 
acceptable medical definition of adequate dialysis does not 
exist and guidelines are not available (Lazarus, 1981; 
Newman, 1983). No single clinical or biochemical measure 
such as BUN or creatinine or a combination of measures has 
proven to be acceptable in defining proper treatment.
However, expectations regarding patient functioning as 
a result of adequate treatment are quite similar. Delano 
(1983) defined adequate dialysis as, "that which permits 
the patient to be rehabilitated, eat a reasonable diet, 
make blood, maintain a normal blood pressure, and prevent
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the development or progression of neuropathy." Newman
(1983) noted the following description of adequate 
treatment, "in addition to acceptable blood chemistries, a 
stable and well-functioning mind and body during and 
between treatments." And Henderson (1983) proposed that 
adequate dialysis should "maintain a patient free of 
symptoms and signs of flagrant uremia (e.g., prevention of 
peripheral neuropathy, pericarditis, pleuritis)".
Medical,Complications
The medical complications associated with maintenance 
dialysis include various mechanical and/or iatrogenic 
complications that can occur during the dialysis procedure; 
medical complications specific to dialysis treatment; and 
persistent uremic problems.
Despite the complexity of the dialysis procedure 
itself, hemodialysis is considered to be relatively safe. 
The risk of death resulting from technical or human error 
in the hemodialysis procedure has been estimated to be 1 in 
76,138 (Friedman & Lundin, 1982).
Dialysis. Hypotension, dialysis disequilibrium
syndrome, muscle cramps, and complications associated with 
anticoagulation are problems frequently encountered as a 
result of the dialysis procedure (Lazarus, 1981).
Episodes of hypotension are common in hemodialysis, 
but rarely occur in peritoneal dialysis. Approximately 20
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to 30^ of hemodialysis sessions involve symptomatic 
hypotension which consists of a drop in blood pressure 
associated with symptoms of pallor, dizziness, malaise, 
unexplained anxiety, nausea, vomiting, and cramps (Blagg, 
1983). These symptoms are thought to be related to the 
volume of excess fluid removed and the rate of removal 
during hemodialysis. Treatment includes administration of 
hypertonic mannitol, isotonic and hypertonic saline.
Dialysis disequilibrium syndrome is no longer a 
frequent complication of maintenance dialysis, although it 
still occurs in association with severe azotemia or when 
rapid dialysis takes place (Lazarus, 1981). The onset of 
symptoms generally occurs at the end of the treatment 
session and may include headache, restlessness, nausea, 
vomiting, blurring of vision, muscle twitching, muscle 
cramps, disorientation, tremors, seizures or coma (Delano, 
1983). The exact etiology is unknown, but a consistent 
finding in these patients is elevated cerebral spinal fluid 
and cerebral edema (Blagg, 1983). It is thought that the 
disequilibrium syndrome may be due to a more rapid 
clearance of urea from the blood than from the cerebral 
spinal fluid. This complication may be prevented or 
minimized by utilizing shorter and more frequent dialysis 
sessions.
Painful muscle cramps are common in maintenance 
dialysis patients and occur both during and between 
treatment sessions. They are thought to be the result of
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hypoosmolality or rapid extracellular volume removal 
induced by sodium shifts out of the muscle cell (Battista, 
1979). Symptomatic relief can usually be obtained with 
increased sodium intake or saline replacement.
Anticoagulants such as heparin are routinely used in 
hemodialysis to prevent clotting of the arteriovenous 
access. Complications arise from an increased incidence of 
spontaneous bleeding episodes which can include subdural 
hematoma, cerebral hemorrhage, gastrointestinal hemorrhage, 
hypermenorrhagia, hemorrhagic effusion in the pericardium, 
pleura, joints, and retroperitoneal space. In addition to 
the administration of anticoagulants, other factors which 
contribute to bleeding episodes include functional platelet 
abnormalities which prolong bleeding time and possible 
increased prostacyclin activity (Blagg, 1983).
Uremia. A number of the symptoms and complications 
associated with the uremic syndrome are not corrected by 
maintenance dialysis.
Although the platelet abnormalities and bleeding 
tendencies associated with chronic renal failure improve 
with maintenance dialysis, anemia persists. Hemodialysis 
may contribute to anemia through added blood loss resulting 
from the dialysis procedure.
Hypertension remains a significant problem in 
maintenance dialysis patients contributing to the high 
incidence of coronary heart disease. Hypertriglyceridemia 
which has been associated with atherosclerotic disease also
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persists despite adequate dialysis. Myocardial infarction 
and cerebrovascular accidents are the most common causes of 
death in chronic renal failure patients on dialysis 
(Lindner, Chara, Sherrard, & Scribner, 1974).
Infection is the second most common cause of death in 
maintenance dialysis patients (Henderson, 1983). 
Infections of the vascular access, diverticulosis, 
diverticulitis, and urinary tract infections are common. 
These patients are particularly at risk for viral 
hepatitis.
Secondary hyperparathryoidism is of particular concern 
in maintenance dialysis patients. If not adequately 
managed, this conditiion can result in severe bone disease. 
Despite adequate dialysis, many patients exhibit
intermittent and mild chronic acidosis which may contribute 
to metabolic bone disease.
Maintenance dialysis will generally halt the 
progression of peripheral neuropathy, but preexisting 
neuropathy will not be significantly improved (Lazarus, 
1981). However, diabetic patients with chronic renal 
disease may evidence progression of peripheral neuropathy 
despite adequate treatment efforts.
Additional uremic symptoms which persist despite 
adequate dialysis include insomnia, restlessness, and




Patients maintained on dialysis receive a
significantly high level of on-going medical supervision 
from physicians and specialized nursing staff as a function 
of their treatment regimen. Consequently, the rate of 
hospitalization, as an index of morbidity, is considered to 
be an extremely important indicator of health and is viewed 
as reflecting more serious alterations in status (Wilson & 
Drury, 1984).
The frequency and duration of hospitalizations over a 
one-year period in 1981 were examined in a large
multicenter regional study of 946 dialysis patients 
(Carlson, Duncan, Naessens, & Johnson, 1984). Data were 
included for patients maintained on hemodialysis, 
continuous ambulatory peritoneal dialysis, and intermittent 
peritoneal dialysis. Results revealed that the mean number 
of hospitalizations per patient during the year was 1.77, 
and the mean duration of hospitalizations was 15.38 days. 
Of the patients who were hospitalized, 15% experienced more 
than three admissions. A trend was noted for an increase 
in the frequency of hospitalizations with advancing age. 
Not surprisingly, both the number of hospitalizations and
the number of hospital days were found to be highest for
dialysis patients who died during the study period. Of the 
1256 of the sample that died during the year, 75% had been 
hospitalized and 57% died in the hospital. Factors
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associated with increased morbidity also included a 
diagnosis of diabetes and other concurrent medical 
disorders such as arteriosclerotic heart disease, 
cerebrovascular accident, malignant lesion, and chronic 
obstructive pulmonary disease. Patients maintained on 
peritoneal dialysis were found to experience a higher rate 
and longer duration of hospitalization than patients on 
hemodialysis. This finding confirmed a similar report by 
Bovberg, Diamond, Held, and Pauly (1983). No differences 
were found in the rate of hospitalization for patients 
maintained on home versus center dialysis programs.
The major causal factors associated with 
hospitalization in this sample, accounting for 50$ of the 
admissions, were reported to be dialysis access problems, 
gastrointestinal diseases, and cardiac disease (Carlson et 
al., 1984). The most common gastrointestinal problem found 
was hemorrhage, and the most frequently occurring 
cardiovascular problems associated with hospitalization 
were ischemic heart disease, cardiac arrhythmias, and 
pericarditis. Other studies of morbidity in dialysis 
patients have reported similar findings. Hirschman, 
Wolfson, Mosimann, Clark, Dante, and Wineman (1981) 
examined 1,049 patients on dialysis for a period of one 
year, and found that 4856 required hospitalization at least 
once . The reasons noted for hospitalization included 
vascular access problems (26%), cardiovascular 
complications (16$), and infections (11$).
Long-term hospitalization, defined as a duration of at 
least three months, was examined in European patients on 
hemodialysis and in patients who had received a first renal 
transplant (Robinson & Hawkins, 1980). Hospital admissions 
for routine dialysis, routine transplant evaluations or 
research were excluded from the analysis. During the first 
year of treatment, 9% of the patients in both groups were 
found to have been hospitalized for periods exceeding three 
months. Again, the data revealed more frequent
hospitalizations with advancing age across treatment 
modalities. Although the findings reflected a lower rate 
of hospitalization for transplant patients across all age 
groups as compared to hemodialysis patients, transplant
failures were associated with a marked increase in 
morbidity.
Mortality
Survival data are available for patients with chronic 
renal failure across treatment modalities including
dialysis procedures and renal transplantation. Krakauer,
Grauman, McMullan, and Creede (1983) presented survival
rates for the United States as a whole based on data 
compiled by the Medical Information System of the Health 
Care Financing Administration. All recipients of medicare 
benefits for end-stage renal disease are included in this 
data which represents 93% of the U.S. population with the
disease. Over 70,000 patients who had begun to receive 
dialysis or who had received a transplant between 1977 and 
1980 were included in the analysis. Overall,
transplantation success, i.e., graft retention, showed 
progressive and substantial increases over this time 
period, whereas survival rates for both dialysis and 
transplant recipients remained relatively stable. Dialysis 
patients were found to be subject to a nearly constant risk 
of death over the first four years of treatment with the 
risk remaining at approximately 19$ per year. Short-term 
survival, defined as one year, for dialysis patients under 
the age of 50 was found to be superior. The data also
supported a finding previously noted by others (Reiman, 
1982; Rostand, Kirk, Rutsky, & Pate, 1982) that the
incidence of chronic renal failure is over three times 
higher among blacks than whites in the U.S. The increased 
incidence in blacks has been attributed to the elevated 
rate of severe hypertensive disease (Reiman, 1982). Blacks 
on dialysis were found to have a lower death rate than 
whites. Table 1 contains one-year and three-year survival 
rates for patients receiving dialysis and transplant 
patients categorized by sex, age, race, and primary 
disease. Comparable one-year survival rates were reported 
for European patients under the age of 55 as compiled by 
the European Dialysis and Transplant Association (1979;
1980; 1981). European data did reflect increased survival
for all dialysis patients at three years. Survival data
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were also analyzed in a multicenter regional study 
(End-Stage Renal Disease Network 7) of 2,725 patients who 
began chronic dialysis or received a renal transplant 
during a five and one-half year study period ending in 1983 
(Hellerstedt, Johnson, Ascher, Kjellstrand, Knutson, 
Shapiro, & Sterioff, 1984). Overall, survival rates 
compared favorably with those of the nation as a whole as 
reported by Krakauer et al. (1983).
Long-term survival of patients with chronic renal 
failure appears to be quite variable across studies. A 
survival rate of 18$ was reported after 12 years in one 
sample of hemodialysis patients (Vollmer, Wahl, & Blagg, 
1983), whereas 85$ of another sample receiving dialysis 
were alive after 10 years (Charra, Calemard, Cuche, & 
Laurent, 1983). In a review of six large scale studies 
which examined survival in chronic hemodialysis patients, 
Gabriel (1984) noted that the reasons for such a wide 
variation in long-term success is not clear at this time. 
A factor which may significantly influence survival data is 
the variation found in the criteria employed for the 
selection of patients with chronic renal failure offered 
treatment. Criteria have been found to differ with respect 
to factors such as age, diagnoses, and associated diseases. 
In 1973, .the Social Security Administration assumed 
responsibility for payment of 80$ of the costs of treating 
chronic renal failure by hemodialysis or renal
T
transplantation, thereby allowing selection criteria to be
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significantly relaxed in centers across the U.S. However, 
variable selection criteria are still found across European 
Centers (Charra et al., 1983).
Factors Affecting Survival. Although it is generally 
accepted that the survival of patients with chronic renal 
failure is clearly age and diagnosis dependent, recent 
studies suggest that other factors may also be important 
(Friedman, Delano, & Butt, 1978). Hellerstedt et al.,
(1984) analyzed over 35 risk factors in a large regional 
study of survival in patients with chronic renal failure 
over five and one-half years. Demographic variables and 
various health parameters were examined in 2,725 patients. 
Results revealed that survival rates were appreciably lower 
for patients with diabetes, irrespective of treatment 
modality. The age of the patient at the time of initiation 
of treatment significantly affected survival with an 
increased risk of mortality found to be associated with 
advancing age. The lowest survival rates were associated 
with a primary diagnosis of malignant lesions including 
renal tumors or multiple myeloma, primary hypertensive 
disease, and diabetes. The highest five-year survival 
rates were found for the primary diagnoses of 
glomerulonephritis, systemic lupus erythematosus, and focal 
glomerulosclerosis. Also the presence of the following 
concomitant morbid conditions at the time of initiation of 
treatment negatively affected survival, irrespective of 
treatment modality: arteriosclerotic heart disease, chronic
pulmonary disease, peripheral vascular disease, and 
noncutaneous malignant lesions. The coexistence of 
multiple morbid conditions were also found to negatively 
effect survival. The outcome of 220 patients who received 
either their first dialysis treatment or first renal 
transplant between 1970 and 1975 was analyzed (Hutchinson, 
Thomas, & MacGibbon, 1982). A number of variables present 
at the time of initiation of treatment were examined to 
determine their effects on prognosis. Three variables, 
accounting for the majority of the variance, were found to 
be related to survival in both dialysis and renal 
transplant patients and included age, diagnosis of diabetes 
mellitus, and the presence of left-sided heart failure as 
evidenced by pulmonary edema. The presence of depression 
was also found to be significantly related to survival, 
although this factor was only present in a small percentage 
of the 220 patients studied.
The effects of psychological, demographic, and 
physiological variables on survival were examined in a 
study of 285 home dialysis patients followed over the 
course of 18 months (Wai, Richmond, Burton, & Lindsay, 
1981). Psychological variables of anxiety, depression, and 
denial were assessed through the use of a structured 
interview. Physiological parameters assessed included 
frequency of excessive interdialysis weight gain, anemia, 
systolic blood pressure, serum creatinine, total protein, 
albumin, potassium, and phosphate levels. Only four
variables were found to significantly discriminate between 
survivors and nonsurvivors which included age, depression, 
level of self-reported stress associated with dialysis, and 
albumin level. No significant differences were found for 
variables thought to be highly related to survival such as 
hypertension or parameters usually indicative of
noncompliance with the medical regimen such as excessive 
fluid gain between dialysis sessions or elevated levels of 
phosphorous. Similarly, Farmer, Bewick, Parsons, and
Snowden (1979) and Foster, Cohn, and McKegney (1973) found 
no significant relation between biochemical measures of 
creatinine, blood urea nitrogen, and hematocrit and
survival. However, the two latter studies examined a large 
number of variables in small samples limiting the
conclusions that can be drawn from their data.
Psychological correlates of survival in hemodialysis 
patients were examined using the Minnesota Multiphasic 
Personality Inventory (MMPI; Ziarnik, Freeman, Sherrard, & 
Calsyn, 1977). Subjects were tested prior to the 
initiation of dialysis, and three groups were compared: 
patients who died during the first year of dialysis, 
patients who remained on dialysis three to seven years, and 
patients who survived seven to ten years. Significant 
differences were found between patients who only survived 
one year and the other two groups on the MMPI. The 
patients who died during the first year evidenced feelings 
of helplessness, high levels of anxiety and depression, and
a preoccupation with somatic difficulties. Patients 
surviving three years or more were characterized by 
dependency and mild levels of depression. Prior to drawing 
any conclusions from the data, the presence of associated 
medical problems such as heart disease, hypertension, 
angina, obesity, diabetes, and stroke were examined for all 
three groups. Significant differences were found, with 
patients who died within the first year of dialysis
demonstrating significantly more associated medical 
problems than the other two groups. It was proposed that 
this factor may have accounted for both the differences in 
survival, as well as the differences in MMPI results.
Other researchers have suggested that severity of illness 
may account for the consistent elevations observed on 
scales 1(Hypochondriasis), 2(Depression), and 3(Hysteria) 
of the MMPI in hemodialysis patients (Osberg, Meares,
McKee, & Burnett, 1982). However, De-Nour and Czaczkes
(1976) reported data that suggests that severe psychiatric 
complications such as depression may have a significant 
impact on the survival of patients in the early stages of 
dialysis. A sample of 120 patients beginning dialysis were 
followed over the course of 36 months. Of the total 
sample, 12.5% died within the first six months of 
treatment. A large percentage of deaths were attributed to
a refusal to continue treatment and suicide.
Recent studies have examined characteristics of 
long-term survivors on dialysis in an effort to delineate
factors associated with increased risk. Guttman (1983) 
compiled data from Sweden and the U.S. on 25 patients who 
had survived on dialysis for 14 years or more. A number of 
health parameters were assessed, and generally these 
patients at the time of the survey were characterized by a 
low prevalence of hypertension and smoking, low rate of 
appreciable cardiovascular morbidity, and compliance with 
the dialysis regimen as reflected by low interdialysis 
weight gain and satisfactory averages and ranges of 
selected chemistries which included serum calcium, 
phosphorous, and alkaline phosphate concentrations. The 
major medical complication experienced by these patients 
was musculoskeletal disease. As noted earlier, Charra et 
al. (1983) reported an excellent 10-year survival rate of
85% in a sample of hemodialysis patients. The authors 
postulated that good control of blood pressure achieved 
through strict regimens of fluid control and low-salt diet 
contributed significantly to the high survival rate. The 
sample was described as completely free of clinical 
evidence of cerebrovascular or ischemic heart disease, 
major causes of death in dialysis patients.
Causes of Death. The most common causes of death in 
patients with chronic renal failure continue to be 
myocardial infarction and cerebrovascular accident. 
Robinson and Hawkins (1980) summarized data on European 
patients on both hemodialysis and peritoneal dialysis from 
the European Dialysis and Transplant Association. Between
the years 1970 and 1980, the five leading causes of death 
for patients on hemodialysis were listed as follows: 
cardiac arrest, cause unknown; cerebrovascular accident; 
other causes of cardiac failure; myocardial infarction; and 
septicemia. For those patients maintained on peritoneal 
dialysis, the leading causes of death were cardiac failure, 
cerebrovascular accident, septicemia, and cachexia. The 
proportion of deaths due to various causes were remarkably 
similar for hemodialysis patients and peritoneal dialysis 
patients.
Three additional causes of death in hemodialysis 
patients warrant review: patients in which a decision is
made to terminate treatment; patients who die from suicide; 
and patients who through their own apathy or neglect 
express an obvious disinterest in survival, i.e., the 
noncompliant patient. Rodin, Chmara, Ennis, Fenton, 
Locking, and Steinhouse (1981) reviewed a sample of 
hemodialysis patients treated between 1976 and 1979. In 
26$ of the 80 deaths that occurred during this time, an 
active decision was made to terminate further treatment 
either initially proposed by the medical staff or by the 
patient, himself. In cases where the staff proposed 
termination, the majority of these patients were considered 
to be mentally incompetent due to severe organic brain 
syndromes usually associated with a grave medical 
condition.
Suicidal behavior has been reported to occur with 
increased frequency in hemodialysis patients. Abram, 
Moore, and Westervelt (1971) estimated the incidence of 
suicide in hemodialysis patients in the United States to be 
100 times that of the general population (10 per 100,000). 
Their findings were based on a survey completed by 125 of 
201 dialysis centers contacted across the United States. 
If patients who had abandoned treatment, i.e., requested 
withdrawal from dialysis programs or refused to accept 
further treatment, were included as suicides, the rate rose 
to 400 times that of the general population.
A more comprehensive study was conducted on the 
occurrence of suicide in hemodialysis patients and patients 
with a functioning renal transplant in Switzerland and 
Europe (Haenel, Brunner, & Battegay, 1980). Questionaires 
were completed by 25 of the 30 hemodialysis centers in 
Switzerland and six renal transplant units. The incidence 
of suicide in hemodialysis patients was found to be similar 
to that of renal transplant patients. The suicide rate 
among both groups was reported to be 10 times that of the 
general population. Again, if the death rate due to 
refusal of treatment is included with the actual suicides, 
the incidence of suicide rose to 25 times that of the 
general population. Data were also obtained from the 
European Dialysis and Transplant Association Registry 
(EDTA) to determine death rates due to suicide and refusal 
of treatment in Europe. For the year 1977, the death rate
attributed to suicide and refusal of treatment in European 
dialysis patients was reported to be 108 per 100,000. This 
finding is considerably higher than that of the general 
population. The World Health Statistics estimated the
death rate due to suicide to be 4-5 per 100,000 in 
Mediterranean countries and 20-25 per 100,000 in Central 
Europe and Scandinavian countries. As Levy (1978) noted, 
suicide statistics are probably in error and exceedingly 
low due to the difficulties involved in accurately
establishing the number of deaths due to suicide.
Nonetheless, the available data does indicate a
significantly higher rate of suicide in hemodialysis 
patients than in the general population. It is difficult 
to determine whether suicide rates for hemodialysis 
patients differ from other groups of chronic illness 
patients due to the absence of comparative studies.
The suicidal behavior found in hemodialysis patients 
has most commonly been associated wih impaired quality of 
life and the high prevalence of depression found in these 
patients (Foster, Cohn, & McKegney, 1973; Levy and 
Wynbrandt, 1975). The high incidence of suicide has also 
been attributed to the fact that hemodialysis patients have 
ready access to means for ending their lives which are not 
available to others (Haenel, Brunner, & Battegay, 1981). A 
method of suicide in these patients is exsanguination,
i.e., disconnecting or cutting of the arteriovenous shunt. 
Also, noncompliance with the dialysis regimen such as
ingestion of large amounts of fluid or foods forbidden by 
the dialysis regimen can result in death. For example, two 
patients in one study died as a result of hyperkalemia in 
which excessive intake of foods rich in potassium caused 
death. Other suicides were reportedly caused by excessive 
salt and fluid intake (Haenel et al., 1980).
Interestingly, Abrams et al., (1971) reported that the 
majority of deaths in hemodialysis patients, not 
necessarily suicides, were related to noncompliance with 
the dialysis regimen. An inability or refusal to adhere to
the numerous restrictions included in the dialysis regimen
has been reported to occur in one-third to one-half of 
patients at any one time (De-Nour, 1970). At what point 
this problematic behavior, i.e., noncompliance, is also 
considered to be suicidal behavior is a perplexing issue 
and may contribute to the high rates of suicide reported by 
various dialysis centers. Other contributing factors 
include the higher than average age of patients on 
maintenance dialysis, and the high incidence of additional 
medical problems found in these patients such as diabetes 
mellitus and neoplastic disease. Further research is
clearly needed to examine the effects of psychological 
factors such as depression and noncompliance on the 
survival of dialysis patients. Nonetheless, noncompliance 
can adversely affect the health status of dialysis




The prognosis for patients with chronic renal failure 
continues to improve as advances in technology become 
available, particularly in the area of renal 
transplantation (Knapp, 1982). The young patient with 
chronic renal failure, under the age of 40 who is 
normotensive and has no coexisting medical problems, has 
the best chances for survival at this time (Gabriel, 1984)-.
It is generally agreed that for patients with chronic 
renal failure a higher quality of life results from a well 
functioning renal transplant than the very best maintenance 
dialysis (Henderson, 1983). However, for many patients 
this alternative is not readily available. Patients can be 
maintained on dialysis for an indefinite period of time, 
but as reviewed, a number of complications are associated 
with this treatment modality and some abnormalities in 
physiological functioning persist despite adequate 
treatment. Additionally, patient noncompliance with the 
complex and demanding medical regimen is a common finding 
in dialysis patients and may contribute significantly to 
the occurrence of medical complications. No other chronic 
illness requires the degree of management by both medical 
personnel and the patient as chronic renal failure.
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Assessment of Health Status in Dialysis Patients
Patients with chronic renal failure maintained on 
dialysis continue to exhibit a wide range of abnormalities 
in physiological functioning and associated physical 
complaints resulting from uremia and the dialysis regimen, 
itself. As in other chronic diseases, the course is highly 
variable with the variance in patient discomfort, level of 
functioning, response to treatment, and disease process 
controlled by a number of complex and interacting variables 
which include both the medical treatment and the influence 
of environmental factors (Cataldo, Russo, Bird, & Varni,
1980). Prior to 1973, older patients and patients with 
significant coexisting morbid conditions were excluded from 
dialysis treatment programs. However, since that time the 
rigid selection criteria have relaxed considerably, and the 
population of patients with chronic renal failure currently 
receiving treatment are both older and more ill. The mean 
age of 93% of the patients with chronic renal failure in 
the U.S. was reported to be 53 (Hellerstedt et al., 1984). 
Also, a large percentage of these patients suffer from 
serious concomitant medical conditions that further impact 
upon health. Calsyn, Sherrard, Freeman, Hyerstay, and 
Curtis (1978) reported that approximately 1/3 of a sample 
of 107 hemodialysis patients suffered from one or more of
the following conditions, in addition to renal failure, at 
the time that dialysis was initiated: cancer, stroke,
myocardial infarction, insulin-dependent diabetes, 
obstructive airways disease, alcoholism, drug addiction or 
psychosis. Charra et al., (1983) noted a shift in the age 
and morbidity of patients entering dialysis treatment 
programs in France in recent years. Patients age 54 and 
older were found to comprise 23/6 of the patients currently 
beginning dialysis treatment. Also, the percentage of 
patients considered to be at high risk due to diagnoses of 
nephrosclerosis, diabetes, and collagen diseases was found 
to have risen from 7% in 1971 to 25% in 1983.
The complexity of variables impacting upon the health 
status of patients maintained on dialysis makes the 
assessment or quantification of health in this population 
exceedingly difficult. Nonetheless, the assessment of 
health parameters remains of critical importance as 
physicians continue to monitor and manage the treatment of 
these patients. The problems inherent in the assessment of 
health in dialysis patients are reflected in the absence of 
clearly defined guidelines for physicians to use in 
assessing the adequacy of treatment (Newman, 1983). Also, 
researchers must have reliable and valid methods for 
assessing health status in order to examine the impact on 
health of various interventions, as well as control for the 
influence of health factors as a potential confound in 
research. A major criticism of psychological research in
this area has been the failure to include an appraisal of 
the physiological status of dialysis patients (Osberg et 
al., 1982). Yanagida and Streltzer (1979) noted that 
biological factors present in many dialysis patients such 
as anemia, hypertension, glucose intolerance, abnormal 
electrolyte levels, fluid overloading, and various 
medications can significantly influence psychological test 
data. A reason given for the omission of illness measures 
in research has been the lack of available assessment 
methodology (Stauch-Rahauser et al., 1977), as well as 
confusion on the part of nonmedical researchers regarding 
the selection of measures considered to be most 
appropriate.
The methods used to assess the health status of 
dialysis patients have included biochemical measures,
physician ratings, symptom checklists, and measures of
functional status.
Biochemical Measures
Serum chemistries reflect a variety of physiological 
parameters of critical importance in patients with chronic 
renal failure who are maintained on hemodialysis. 
Laboratory values of creatinine, blood urea nitrogen,
hematocrit, potassium, phosphorous, calcium, sodium, carbon 
dioxide, chloride, alkaline phosphatase, and others are
carefully observed and continuously monitored by the
medical staff to assess the health status of dialysis 
patients (Hekelman & Ostendarp, 1979). These data are used 
to assess the adequacy of the treatment regimen in an 
effort to identify potential medical problems. The
on-going evaluation of serum chemistries can impact upon
the dialysis treatment regimen suggesting a need for 
changes in dialysis parameters, initiation or
discontinuation of drug therapy or modification of diet. 
Many of the laboratory values such as potassium and 
phosphorous are viewed as objective measures of patient 
compliance (Agashua, Lyle, Livesley, Slade, Winney, & 
Irwin, 1981). For example, Blackburn (1977) assessed
compliance with the dialysis regimen through laboratory 
values, and noted that only 25$ of patients in one sample 
were potassium compliant, and 60$ were phosphorous 
compliant.
In addition to the routine monitoring of chemistries 
by the medical staff, researchers have also employed 
laboratory values as an index of physical status in 
dialysis patients. Trieschmann and Sand (1971), in an 
investigation of psychological functioning in predialysis 
patients, used creatinine level, an index of the degree of 
impairment in renal function, to differentiate patients 
into "most sick” and "least sick" groups. Yanagida and 
Streltzer (1979) stressed the importance of including 
physiological measures in dialysis research to avoid 
misinterpreting differences among groups as due to
psychological factors when biological factors may be 
causitive. In a further study, these researchers examined 
two groups of dialysis patients for differences in 
physiological status through an assessment of serum levels 
of blood urea nitrogen, hematocrit, creatinine, calcium, 
potassium, phosphorous, sodium, chloride and carbon dioxide 
in order to ensure equality on a number of potentially 
confounding variables (Yanagida, Streltzer, & Siemsen,
1981). The finding that significant correlations exist 
between both blood urea nitrogen and creatinine and 
performance on tasks that assess visuomotor speed and 
accuracy in dialysis patients led researchers to warn 
others about the need to control for, or at least assess, 
the potentially confounding effects of physiological status 
in future research (Hart, Pederson, Czerwinski, & Adams, 
1983).
As noted previously, medically, the physiological 
parameters reflected in serum chemistries are viewed as 
critical to patient survival. However, longitudinal 
studies of factors related to survival in dialysis patients
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generally do not consistently find any one biochemical 
measure to be highly predictive of longevity (e.g., Wai et 
al., 1981). It is likely that when such measures are
entered into predictive equations with powerful
demographic variables such as age, their impact are 
considerably lessened. Further, studies completed to date 
such as Foster et al., (1973) include methodological
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shortcomings such as grossly inadequate sample size which 
preclude the drawing of firm conclusions. Further research 
is clearly needed directed at the relation between 
biochemical measures and other measures of health status.
Physician Ratings
Physician ratings are frequently employed in an effort 
to quantify the physical status of dialysis patients. 
Dialysis patients receive a significantly high degree of 
routine medical supervision. In-center dialysis patients 
are generally seen by a physician during each dialysis 
session. As a result, staff physicians (nephrologists), 
who usually complete such ratings, have a thorough and 
on-going knowledge of each patient's medical status. 
Chambers (1982) pointed out the potential bias in 
physician's assessments which can result from prior 
expectations and past knowledge of the patient. De-Nour 
and Czaczkes (1974) examined the criteria employed by staff 
physicians in the assessment of their patients, and 
compared physician ratings with other indices of patient 
functioning. Overall, their data suggested that physician 
ratings were biased, because they tended to minimize 
patient problems and rate their patients as doing better 
than other indicators would suggest. Additionally,
physician rating scales present difficulties due to the 
reliance on clinical judgment, making them hard to
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standardize and calibrate. However, these methodological 
concerns can be adequately controlled through the use of 
two independent ratings and demonstrating high levels of 
interrater reliability.
A variety of formats for physician rating scales have 
been used with dialysis patients. Most commonly, a global 
rating scale has been employed in which the medical status 
or overall health of patients are rated on a 4-point scale 
ranging from good to very bad (e.g., De-Nour, 1982). 
Devins, Binik, Hollomby, Barre, and Guttman (1981) had 
attending physicians rate each dialysis patient's general 
nonrenal health along a 5-point scale, in an effort to 
exclude patients with serious nonrenal pathology from 
further study. A modified Karnofsky Performance Status 
Scale was used to assess the physical activity level of 25 
dialysis patients (Guttman, 1983). Staff physicians rated 
each patient on a 5-point scale ranging from very active to 
moribund. A 7-point rating scale was employed to measure 
overall medical condition in 23 dialysis patients (Steidl 
et al., 1980). Three staff physicians and the head nurse 
of the dialysis unit rated each patient, and satisfactory 
interrater reliability was reported. Staff ratings were 
also validated against the Cornell Medical Index, and 




As previously reviewed, patients maintained on 
hemodialysis continue to experience a number of physical 
symptoms resulting from persistent physiological 
abnormalities secondary to chronic renal failure and the 
dialysis procedure, itself. As Kutner, Fair, and Kutner
(1985) emphasized, dialysis patients are likely to 
experience a myriad of somatic symptoms such as nausea, 
dizziness, muscle cramps, and chronic fatigue, even in the 
absence of serious coexisting medical conditions. The 
occurrence and frequency of physical symptoms have been 
viewed as an important index of health status in dialysis 
patients, and such measures are routinely employed in the 
assessment of the adequacy of dialysis treatment (Newman, 
1983).
Strauch-Rahauser, Schafheutle, Lipke, and Strauch
(1977) developed an instrument specifically designed to 
assess the presence of physical symptoms in dialysis 
patients. The symptom checklist consists of 54 somatic 
items which cover a broad range of symptomatology. All 
items were judged to be of significance in the assessment 
of physical status in dialysis patients by 100 
nephrologists in Germany. It is easily administered, and 
was found to produce a wide range of scores in a sample of 
dialysis patients. Adequate interrater reliability was 
found for this scale, but limited data is available related
to its validity. The KDS-2 form (Kupfer & Detre, 1972) was 
also used to assess physical symptomatology in 190 dialysis 
and transplant patients (Bonney, Finkelstein, Lytton, 
Schiff, & Steele, 1978). The KDS-2 is a symptom checklist 
containing 64 specific physical symptoms. Significant 
differences were found between dialysis patients and 
transplant patients with 3856 of the dialysis group 
endorsing more than 20 symptoms, whereas only 956 of the 
transplant group did so. These findings are contrasted 
with a group of healthy controls where none were found to 
reply positively to more than four symptoms on this scale. 
Other researchers have employed widely used instruments 
such as the Cornell Medical Index to assess symptomatology 
in dialysis patients (Steidl et al., 1980). Other more 
global ratings of overall physical symptom severity based 
upon interview data have also been used (Farmer, Bewick, 
Parsons, & Snowden, 1979).
Functional Status Measures
The functional status of patients maintained on 
dialysis is of primary concern in the rehabilitation 
process. Levy (1977) defined rehabilitation as efforts to 
"restore to a condition of health for useful and 
constructive activity". The goal for treatment of patients 
with chronic renal failure is not only to sustain life, but 
also reduce the limitations and restrictions in functioning
that are commonly observed (Bonney et al., 1978). 
Frequently, successful adjustment on dialysis is viewed as 
a return to the level of employment and physical and social 
activities that a patient experienced before becoming 
severely uremic. However, a sizable literature is 
available regarding the functioning of dialysis patients, 
and for many such a level of functional status is not 
easily achieved. For example, the proportion of patients 
on dialysis working full-time, an index of vocational 
rehabilitation, was been reported to range from Q% to 51 it 
(Disney & Row, 1974; Strauch, Huber, Rahauser, Werner, 
Walzer, & Hefner, 1971).
The assessment of functional status in dialysis 
patients generally targets the areas of mobility, 
occupation, activities of daily living, and general 
activity level (Chyatte, 1979). More specific areas of 
functioning such as strength, range of motion, sensation, 
timed mobility, and fatigue may also be assessed. Most 
often, researchers have employed the functional 
classification system recommended by the National Kidney 
Foundation. This 4-point rating scale primarily assesses 
general physical activity ranging from 1 (capable of 
performing all usual types of physical activity) to 4 
(severe limitation of usual physical activity). Steidl et 
al., (1980) used the classification system to assess the 
overall medical condition of a sample of dialysis patients. 
The staff physician, nurse, and social worker completed the
scale for each patient, and satisfactory interrater
reliability was reported. Other researchers utilized this 
rating scale together with a structured interview to elicit 
an overall assessment of functional status (Bonney et al., 
1978). Of the 190 dialysis and transplant patients, 35?6 of 
the dialysis patients and 10£ of the transplant patients 
received a functional status rating of 3 or 4, suggesting a 
substantial interference in their ability to perform usual 
daily activities. A fairly comprehensive questionnaire, 
the Psychosocial Adjustment to Illness Scale (PAIS), was 
designed to assess the functioning level of dialysis 
patients across seven areas including health care
orientation, vocational environment, domestic environment, 
sexual relationships, extended family relationships, social 
environment, as well as psychological distress (De-Nour,
1982). It is a self-administered format that assesses
perceived limitations in functioning. It contains 44 items 
which are rated on a 4-point scale ranging from 0 (no 
disturbance) to 3 (marked disturbance). Adequate
psychometric properties support( its use in obtaining 
information related to global adjustment and psychological 
functioning in specific areas.
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The Present Research
Increasing emphasis is being placed upon the 
development of assessment methodology targeting health 
parameters. The availability of reliable and valid 
measures of health status for use with dialysis patients is 
of critical concern to both medical professionals and 
researchers. Although a variety of assessment procedures 
have been used clinically and in research, little data is 
available regarding the psychometric properties of these 
instruments. There remains a need to examine the 
interrelation among the various methods of assessing health 
in dialysis patients. Also, the relation between measures 
of health status and other variables previously found to 
impact the health of these patients needs to be examined. 
Of particular concern is the lack of a demonstrated 
relation between various measures used to index health and 
important health outcomes for patients maintained on 
dialysis. The relation between health status measures and 
subsequent medical utilization has not been investigated. 
There is also clearly a need to examine the utility of 
various health indices in discriminating between those 
patients on dialysis who will continue to survive and those 
patients at risk for dying.
The present study was designed to examine the 
concurrent and predictive validity of a number of health 
status measures including biochemical measures, physician
ratings of physical status, staff ratings of functional 
status, Wahler Physical Symptoms Inventory, subjective 
ratings of health, and subjective ratings of functional 
status in hemodialysis patients. Also, of interest are the 
demographic and medical variables of age, length of time on 
hemodialysis, diagnosis of diabetes mellitus, diagnosis of 
primary hypertension, and total number of concomitant 
morbid conditions which have been previously identified to 
be significantly related to health in hemodialysis 
patients, and their relation to measures of health status. 
If evidence for the concurrent and predictive validity of 
these measures of health status can be established, such 
data will be useful to physicians, as well as researchers 
in determining the health status of hemodialysis patients. 
The following questions are of most importance:
1. What is the relation among various measures of health 
status in hemodialysis patients?
2. What is the relation among measures of health status 
and previously identified significant demographic and 
medical variables?
3. What is the relation of various indices of health to 
subsequent medical utilization and survival?
4. What measure of health status best predicts subsequent 
medical utilization and survival?
5. What is the relation among previously identified 
significant demographic and medical variables to both 




Subjects consisted of adult outpatients with chronic 
renal failure who were receiving maintenance hemodialysis 
at Bio-Medical Applications of Baton Rouge, Inc. An effort 
was expended to recruit all routine hemodialysis patients 
in order to provide a full range of scores on the measures 
of health status. Of the 158 patients receiving
hemodialysis at the two outpatient clinics in the 
community, 91% served as subjects in the initial assessment 
phase of the present investigation. Three patients 
declined participation, and 12 patients were excluded 
because of severe physical impairment resulting from 
stroke, blindness, mental retardation or critically ill 
medical status that significantly interferred with 
completion of assessment instruments. Eight subjects who 
initially participated in assessment received a renal 
transplantation during the one-year course of the 
investigation and were subsequently dropped from the study. 
Four additional subjects transferred to another dialysis
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facility, and complete data for these patients were not 
available. Data from 131 subjects were available for 
analysis.
The age of participating hemodialysis patients ranged 
from 20 to 78 years, with a mean age of 52 years. The 
sample was predominantly black (71%), unemployed (8456), and 
of lower socioeconomic status as measured by the 
Hollingshead Two-Factor Index of Social Status. The length 
of time on hemodialysis, measured in months since initial 
onset of maintenance treatment, ranged from 1 to 152 
months, and the mean length of time for the sample was 39 
months at the time of the initial assessment phase of the 
investigation. These and other demographic data are 
presented in Table 2.
Measures of Health Status
Biochemical analyses of blood urea nitrogen, 
potassium, phosphorous, and hematocrit; physician ratings 
of physical status; Wahler Physical Symptoms Inventory; 
staff ratings of functional status; subjective ratings of 
functional status; and subjective ratings of health served 
as measures of health status.
Biochemical analyses. Plasma levels of blood urea 
nitrogen (normal values: 10-26 mg/dl); potassium (normal
values: 3.5-5.0 mg/dl); phosphorous (normal values: 2.5-4.2 
mg/dl); and hemocrit (normal values: 38-5256) were
determined for each subject by assays performed on a 
Technicon-SMAC-2 by Lifechem Laboratories, Rockleigh, New 
Jersey. This laboratory performs routine biochemical 
assays on a monthly basis for all patients and staff at 
Biomedical Applications of Baton Rouge, Inc., as well as 
numerous dialysis centers throughout the United States. 
The reliability of the assay procedures is continuously 
monitored, and the instrumentation is calibrated after 
every ten samples. Normal samples are included at random 
intervals as a further check on reliability. Additionally, 
if a sample is found to be significantly abnormal, the 
laboratory requests that another plasma sample be drawn and 
the analysis is repeated.
Physician ratings of physical status. An adaptation 
of a seven-point rating scale developed by Steidl et al. 
(1980) was used to obtain an assessment of each subject's 
current medical condition. A previous application of this 
scale with hemodialysis patients yielded satisfactory 
interrater reliability (.77 to .89), and physician ratings 
were found to be significantly correlated with both ratings 
of functional status (.75) and the Cornell Medical Index 
(.50). Two staff physicians at Bio-Medical Applications of 
Baton Rouge, Inc. independently rated each subject. 
Physicians were asked to define a score of 1 as the patient 
is doing well, in a global sense, in terms of medical 
adjustment; and a score of 7 as the patient is suffering 
from and is incapacitated by extremely severe medical
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complications of his/her illness. An anchored scale was 
provided to assist physicians in making this determination 
(see Appendix A). Interrater reliability was calculated, 
and mean scores were used to provide a single rating for 
each subject.
Wahler Physical Symptoms Inventory. The Wahler
Physical Symptoms Inventory is a brief self-report 
questionnaire that was administered to each subject. 
Reliability and validity data regarding this inventory have 
been previously reviewed. Forty-two physical symptoms are 
included, and respondents were asked to provide a frequency 
rating for each item on a scale of 0 (almost never) to 5 
(nearly every day). Additional anchors are provided to 
assist subjects in providing frequency ratings (see 
Appendix B). The total score reflects the sum of all 
ratings provided after the number of items omitted or given 
more than one score are subtracted.
Staff ratings of functional status. Functional
status or degree of disability was assessed through ratings
of each subject provided by the staff social worker and
(
staff dietician at Bio-Medical Applications of Baton Rouge, 
Inc. Each subject was rated on a 4-point scale according 
to the functional classification system recommended by the 
National Kidney Foundation (see Appendix C). In this 
system, a score of 1 is defined as the patient is capable 
of performing all usual types of physical activity, and a 
score of 4 is defined as the patient is experiencing severe
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limitations in usual activity level, may need assistance
with some aspects of self-care, may have impaired
mentation, may be confined to bed. Additional anchors were 
provided to assist in determining ratings. Interrater 
reliability was calculated, and mean scores were obtained 
to provide a single rating per subject. Previous 
interrater reliability coefficients ranged from .71 to .88 
(Steidl et al., 1980).
Subjective ratings of functional status. A 4-point 
rating scale that parallels the ratings of functional 
status completed by the staff social worker and dietician 
were completed by each subject. Subjects were asked to 
rate their current level of physical activity on a scale 
with a score of 1 defined as the patient is capable of 
performing all usual types of physical activity, and a 
score of 4 defined as the patient is experiencing severe 
limitations in usual activity level, may need assistance
with some aspects of self-care, may have impaired
mentation, may be confined to bed (see Appendix D).
Subjective ratings of health. A 4-point rating scale 
was used for subjective ratings of current health. 
Subjects were asked to define a score of 1 as excellent, 2 
as good, 3 as fair, and a score of 4 as poor (see Appendix
E). As reviewed, self-assessed health status is often 
considered to be one of the best single indicators of 
health particularly due to its relation with subsequent
mortality (Kaplan & Camacho, 1983).
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Demographic/Medical Variables
A number of demographic and medical variables have 
been previously identified to be significantly related to 
survival in hemodialysis patients. The demographic and
medical variables examined in the present investigation 
included age, length of time on hemodialysis, diagnosis of 
diabetes mellitus, diagnosis of primary hypertension, and 
total number of coexisting morbid conditions present in 
addition to chronic renal failure. Demographic and medical 
information was obtained from the medical records at
Bio-Medical Applications of Baton Rouge, Inc. The
information contained in the Medical records was compared 
to available hospital discharge summaries in an effort to 
insure completeness of diagnostic data. The total number 
of coexisting morbid conditions was determined by the 
presence of the following diagnoses: hypertension,
congestive heart failure, diabetes mellitus, 
arteriosclerotic cardiovascular disease, chronic
obstructive pulmonary disease, malignancy, liver disease, 
and systemic lupus erythematosus.
Medical Utilization
The rate of medical utilization was defined as the
frequency of hospitalizations and number of hospital days 
for each subject during a one-year interval. This data was
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obtained from the medical records at Bio-Medical 
Applications of Baton Rouge, Inc. Hospitalizations and 
hospital days associated with a renal transplant procedure 
or dialysis access problems were omitted from this data.
Survival
Survival data for the entire sample over a one-year 
interval were also obtained from the medical records at 
Bio-Medical Applications of Baton Rouge, Inc. Date and 
cause of death for deceased subjects were ascertained in 
order to determine length of survival for each subject.
Procedure
All subjects were required to complete one 20-minute 
assessment session which was scheduled during routine 
hemodialysis administration. A consent form (see Appendix
F) was signed by both the subject and the experimenter at 
the onset of the assessment session. Subjects were told 
that the objective of the present study was to examine 
measures of health status in hemodialysis patients.
During the assessment session, subjects completed the 
Wahler Physical Symptoms Inventory, subjective ratings of 
functional status, and subjective ratings of health. These 
measures were administered orally by the experimenter, 
precluding the need for subjects to be able to write while
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receiving hemodialysis. This precaution was taken because 
the hemodialysis access site is frequently located in a 
patient's dominant arm.
Pertinent demographic and medical information 
including age, sex, length of time on dialysis, medical 
diagnoses, and medications were obtained from each 
subject's medical records at Bio-Medical Applications of 
Baton Rouge, Inc. (see Appendix G). Biochemical analyses 
of blood urea nitrogen (BUN), potassium, phosphorous, and 
hematocrit were also obtained from the medical records. 
Plasma samples are routinely drawn from each patient on a 
monthly basis and assayed by Lifechem Laboratories, and 
these data are recorded in each patient's medical chart.
Physician ratings of each subject were completed 
independently by two staff physicians, and ratings 
coincided with the assessment session and drawing of 
monthly plasma samples from each subject. Functional 
classification of each subject by the staff social worker 
and dietician were performed on the same day as physician 
ratings.
The rate of medical utilization, i.e., frequency of 
hospitalizations, number of hospital days, and survival 
data (date and cause of death) were obtained for each 
subject over a 12-month period following the initial 
assessment of health status. This data was contained in 





The means and standard deviations for the measures of 
health status are presented in Table 3- Also, the range of 
normal values for each biochemical measure are included for 
comparison purposes. Physician ratings of physical status 
reflect the mean rating of two staff physicians; interrater 
reliability, r = .73. Staff ratings of functional status 
reflect the mean rating of the staff social worker and 
dietician; interrater reliability, r = .77.
The interrelations among the measures of health status 
were examined using Pearson product-moment correlations as 
presented in Table 4. The correlation matrix contains 
unadjusted alpha levels to facilitate comparison with other 
studies. However, the Bonferroni procedure (Dunn, 1961) 
for correlations was employed to control the 
experiment-wise error rate likely because of the large 
number of correlations. Utilizing this procedure, 
correlations in Table 4 are considered to be significant 
only if at the .001 level. Blood levels of blood urea 
nitrogen (BUN), potassium, and phosphorous were 
significantly intercorrelated in the present sample, but
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showed little relation to the other measures of health 
status. Further, hematocrit failed to correlate 
significantly with any other measure of health status. 
Substantial correlations were found among physician ratings 
of physical status, staff ratings of functional status, the 
Wahler Physical Symptoms Inventory, subjective ratings of 
health, and subjective ratings of functional status. Only 
the correlation between subjective ratings of health and 
staff ratings of functional status failed to reach 
significance. Staff and physician ratings were highly 
correlated, r = .73, £. < .0001, suggesting a significant
degree of agreement in the dialysis staff's perceptions of 
patients' level of illness and disability. Of note, staff 
and patient ratings of functional status showed substantial 
agreement, r = .68, £ < .0001.
The relations among the measures of health status and 
a number of demographic and medical variables identified in 
previous research to be significantly related to health in 
hemodialysis patients was also examined in the present
investigation. Means, standard deviations, frequency, and
percentage of the demographic/medical variables are
presented in Table 5. The total number of concurrent 
diagnoses reflects the sum of the eight diagnostic 
categories contained in Table 5.
The intercorrelations among the measures of health 
status and the demographic/medical variables are presented 
in Table 6 along with £ values. Again, the Bonferroni
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procedure (Dunn, 1961) for correlations was employed to 
control the experiment-wise error rate likely due to the 
large number of correlations. Utilizing this procedure, 
correlations in Table 6 are only considered statistically 
significant at the .0005 level. Inspection of Table 6 
reveals that none of the biochemical measures were
significantly correlated with the demographic/medical
variables. Also, no significant relations were found
between subjective ratings of health and any
demographic/medical variable. Physician ratings of 
physical status were substantially correlated with a
dignosis of diabetes mellitus, r = .34, £  ̂ *0001, and the
total number of concurrent diagnoses present in addition to 
chronic renal failure, £ = .44, £ < .0001. Functional
status, as reflected by both staff and subjective ratings, 
respectively, was significantly correlated with age, r = 
.49, .38; £ < .0001. Additionally, subjective ratings of
functional status showed a significant relation to a
diagnosis of diabetes mellitus, r = .31, £ < .0003. Scores
on the Wahler Physical Symptoms Inventory were found to 
correlate significantly only with total number of 
concurrent diagnoses, r = .37, £ < .0001. Interestingly, a 
diagnosis of primary hypertension or nephrosclerosis showed 
no relation to the measures of health status, nor did this
variable correlate significantly with any other
demographic/medical variable. It is likely that this 
finding is due to the high prevalence of primary
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hypertension in the present sample, having been diagnosed 
in 48.156 of the subjects.
In summary, the correlational data presented in Tables 
4 and 6 suggest that the biochemical measures may be 
assessing a separate aspect of functioning in dialysis 
patients as compared with the other measures of health
status. Moreover, the pattern of correlations lends
support to the concurrent validity of physician ratings of
physical status, staff ratings of functional status, the 
Wahler Physical Symptoms Inventory, and subjective ratings 
of functional status as measures of the construct of health 
status.
Predictive Validity
Multiple regression and discriminant analysis 
procedures were used to examine the relations between 
indices of health status, demographic/medical variables and 
subsequent medical utilization and survival in the present 
sample of hemodialysis patients. The rate of medical 
utilization, defined as the frequency of hospitalizations
and number of hospital days, and survival for the sample 
over a one-year interval served as criterion variables. 
Table 7 contains the means, standard deviations, frequency, 
and percentage of the criterion variables. As presented in 
Table 7, 18 subjects (13.7/6 of the sample) died during the 
one-year study period. The number of hospitalizations and
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number of hospital days were scaled in subsequent analyses 
in order to control for the limited number of available 
hospitalizations and/or hospital days for the subjects who 
died during the study interval. The scaling procedure 
utilized the proportion of hospitalizations and hospital 
days, respectively, to the number of available days for 
each subject over the one-year interval.
Table 8 contains the Pearson-product moment 
correlations between the measures of health status, 
demographic/medical variables, and the criterion 
variables. Although these correlations provide some 
information regarding the relation between the predictors 
and the criterion variables, the correlational procedure 
does not take into account the degree of intercorrelation 
among the predictors. To compensate for the moderate 
intercorrelations among the predictors, separate multiple 
regression analyses were utilized to predict number of 
hospitalizations and number of hospital days.
Number of hospitalizations. Separate multiple 
regression analyses were performed using number of 
hospitalizations as the criterion variable and the 
following sets of predictor variables: measures of health 
status, demographic/medical variables, and the combined 
measures of health status and demographic/medical 
variables.
The measures of health status were entered into a 
standard multiple regression analysis. As displayed in
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Table 9, the analysis was significant, F(9, 115) = 2.24, £
2
< .02, R = .15. Table 10 contains the subsequent stepwise 
multiple regression analysis for the measures of health 
status. As can be seen from Table 10, physician ratings of 
physical status were the best predictor of number of 
hospitalizations, F(1, 123) = 10.62, £ < .001, accounting
for 856 of the variance. The addition of phosphorous level 
accounted for an additional 4$ of the variance, yielding a 
significant two-variable model, F(2, 122) = 8.24, £ <
.0004. Subjective ratings of health accounted for an
additional 256 of the variance, F(3, 121) = 6.37, £ < .0006. 
The addition of the Wahler Physical Symptoms Inventory, 
subjective ratings of functional status, potassium, and 
hematocrit, respectively, did not add significantly to the 
prediction.
The demographic/medical variables of age, length of 
time on dialysis, diabetes mellitus, primary hypertension, 
and total number of coexisting morbid conditions were 
entered into a standard multiple regression analysis. The 
analysis, summarized in Table 11, was significant, F(5,
2
123) = 2.73, £ < .02, R = .10. Table 12 contains the
subsequent stepwise multiple regression analysis for the 
demographic/medical variables. Inspection of Table 12 
reveals that the total number of coexisting morbid 
conditions best predicted the number of hospitalizations, 
F( 1, 127) = 5. 34, £ < .02, accounting for 456 of the
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variance. The addition of the length of time on dialysis 
in a two-variable model accounted for an additional 4% of 
the variance, F(2 , 126) = 5.31, £ < .006. The
three-variable model of total number of concurrent morbid 
conditions, length of time on dialysis, and age accounted 
for a total of 9% of the variance in number of
hospitalizations, F(3 , 125) = 3*96, £ < .009. The addition 
of the variables of diabetes mellitus and primary
hypertension did not add significantly to the prediction.
The combined measures of health status and the
demographic/medical variables were entered into a standard
multiple regression analysis. As displayed in Table 13,
the analysis was significant, F(14, 108) = 2.02, £ < .02,
2
R = .21. The subsequent stepwise multiple regression
analysis for the combined variables is presented in Table 
14. As displayed in Table 14, physician ratings of physical 
status best predicted number of hospitalizations, F(1, 121) 
= 9 *66, £ <.002, accounting for 7% of the variance. The
addition of length of time on dialysis accounted for an
additional 6% of the variance, F(2, 120) = 8.70, £ < .0003. 
Phosphorous level accounted for an additional 3% of the 
variance, F(3, 119) = 7.56, £ < .0001. Only the addition of 
subjective ratings of health in a four-variable model added 
significantly to the prediction, F(4, 118) = 6.21, £ <
.0001.
Number of hospital days. Two subjects evidenced
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extreme scores on the criterion variable of number of 
hospital days, totally 93 and 142 hospital days, 
respectively. Because of the deleterious effects that 
extreme scores may have on multiple regression analyses, 
the data were analyzed intially with the outliers included 
and then with the two outliers excluded according to 
recommendations by Tabachnick and Fidell (1983, p. 92). 
Both analyses are presented for comparison.
Separate multiple regression analyses were performed 
for thd criterion variable of number of hospital days with 
the outliers included utilizing the following sets of
predictor variables: health status measures,
demographic/medical variables, and combined measures of 
health status and demographic/medical variables.
The measures of health status were entered into a 
standard multiple regression analysis utilizing the
criterion of number of hospital days with the outliers
included. As displayed in Table 15, the analysis was not
2
significant, F(9, 115) = 1.56, £ < .14, R = .11.
Therefore, no stepwise multiple regression analysis was 
performed.
The demographic/medical variables were entered into a 
standard multiple regression analysis utilizing the
criterion variable of number of hospital days with the
outliers included. As displayed in Table 16, the analysis
2
was not significant, F(5, 123) = 1.175, £ < .13, R = .07.
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Therefore, no subsequent multiple regression analysis was 
performed.
The combined measures of health status and 
demographic/medical variables were entered into a standard 
multiple regression analysis utilizing the criterion 
variable of number of hospital days with the outliers 
included. As displayed in Table 17, the analysis was
2
significant, F(14, 108) = 1.91, p. < .03, R = .20. A
subsequent stepwise multiple regression analysis was 
performed and is presented in Table 18. Physician ratings 
of physical status were found to be the best predictor of 
number of hospital days, accounting for 1% of the variance, 
F(1, 121) = 8.67, p < .004. The variable of length of time
on dialysis accounted for an additional 1% of the variance, 
F(2, 120) = 9•63, p < .0001. Only the addition of a
diagnosis of diabetes mellitus in a three-variable model 
significantly improved the prediction, F(3, 119) = 8.25, p 
< .0 0 0 1.
Separate multiple regression analyses were performed 
with the outliers excluded from the criterion variable of 
number of hospital days utilizing the same sets of 
predictor variables which included the health status 
measures, demographic/medical variables, and the combined 
measures of health status and demographic/medical 
variables.
The measures of health status were entered into a
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standard multiple regression analysis utilizing the
criterion variable of number of hospital days with the
outliers excluded. As displayed in Table 19, the multiple
regression analysis was not significant, F(9, 113) = 1*74, 
2
2 < .09, R = .12. Therefore, no subsequent stepwise
multiple regression analysis was performed.
The demographic/medical variables were entered into a 
standard multiple regression analysis to predict the 
criterion variable of number of hospital days with the
outliers excluded. As presented in Table 20, the standard 
multiple regression analysis was significant F(5, 121) =
2
4.40, £ < .001, R = .15. A subsequent stepwise multiple
regression analysis was performed and is summarized in 
Table 21. As displayed, the length of time on dialysis was 
the best predictor of the number of hospital days, F(1, 
125) = 14.18, 2 < .0003, accounting for 10^ of the
variance. The total number of concurrent diagnoses 
accounted for an additional 3% of the variance, F(2, 124) = 
9.34, 2 < .0002. Only the addition of the variable of
diabetes mellitus in a three-variable model added 
significantly to the prediction, F(3, 123) = 6.72, 2 <
.0004.
The combined measures of health status and the 
demographic/medical variables were entered into a standard 
multiple regression analysis to predict the criterion of 
number of hospital days with the outliers excluded. As
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presented in Table 22, the analysis was significant, F(14,
2
106) = 2.39, £ <.006, R = .24. A subsequent stepwise
multiple regression analysis was performed and is presented 
in Table 23* As shown, the length of time on dialysis was 
the best predictor of hospital days, F(1, 119) = 15.69, £ < 
.0001, accounting for 12$ of the variance. Physician 
ratings accounted for an additional 4$ of the variance, 
F(2, 118) = 11.11, £ < .0001. Only the addition of the
variable blood urea nitrogen in a three-variable model 
added significantly to the prediction, F(3, 117) = 8 .98, £
< .0 0 0 1.
In summary, the measure of health status that best 
predicted medical utilization in the present sample was 
physician ratings of physical status. Even when considered 
in combination with important demographic and medical 
variables, physician ratings were consistently the best 
predictor of subsequent medical utilization.
Survival. Separate direct linear discriminant function 
analyses were performed utilizing the measures of health 
status, the demographic/medical variables, and the combined 
health status measures and demographic/medical variables as 
predictors of survival. The discriminant analyses were 
used to classify subjects into groups (survivor versus 
deceased) on the basis of their scores on the independent 
variables.
For each set of predictor variables, the total sample
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(N = 131) was randomly divided into a calibration sample 
and a holdout sample. The calibration sample was used to 
develop the discriminant function model, which was then 
applied to the holdout sample. In this way, the model was 
cross validated to enhance the external validity of the 
findings. Also, to minimize the effects of chance, the
largest possible calibration or modeling sample was 
utilized. Although a 75:25 split between the calibration 
and holdout samples is viewed as optimal, this was not 
feasible due to the small size of the deceased group.
Consequently, a 67:33 split was employed for each
subsequent discriminant function analysis.
A direct discriminant function analysis procedure, a 
method for computing the discriminant function which 
considers all independent variables concurrently, was 
performed using the measures of health status as predictors 
of survival. The calibration sample consisted of 69
survivors and 13 deceased subjects. The standardized 
linear discriminant function coefficients developed on the 
calibration sample with .84 prior probability of correct 
classification are presented in Table 24. The resultant
classification of subjects into survivor versus deceased 
groups is summarized in Table 25. In the calibration 
sample, 85$ (70 from a total of 82) of the subjects were 
correctly classified and 15$ (12 from a total of 82) were 
incorrectly classified into survivor and deceased groups. 
As indicated, 67 subjects or 97.10$ of the surviving group
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were correctly classified as survivors, while 2 subjects or 
2.90% of the surviving group were incorrectly classified as 
deceased. In the deceased group, 3 subjects or 23.08% were 
correctly classified as deceased, while 10 subjects or 
76.92% from the deceased group were incorrectly classified 
as survivors.
The holdout sample consisted of 38 survivors and 5 
deceased subjects, yielding a maximum chance criterion of 
.88. The model was applied to the holdout sample, and the 
resultant classification of subjects into survivor versus 
deceased groups is summarized in Table 26. As displayed, 
91% (39 from a total of 43) of the subjects were correctly 
classified, and 9% (4 from a total of 43) were incorrectly 
classified into survivor and deceased groups. Thus, the
model surpassed the maximum chance criterion. As indicated 
in Table 26, 37 subjects or 97-37% from the surviving group 
were correctly classified as survivors, while 1 subject or 
2.63% from the surviving group were incorrectly classified 
as deceased. However, in the deceased group, only 2 
subjects or 40% of the deceased group were correctly 
classified as deceased, while 3 subjects or 60% from the
deceased group were incorrectly classified as surviving. 
Therefore, despite a significant difference in the
proportion of subjects classified into the survivor and 
deceased groups as indicated by a Fisher Exact Probability 
Test = .03, the model misclassified the majority of the 
deceased group. It is important to note that the Fisher
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Exact Probability Test, like the Chi-Square Test, analyzes 
deviation in any direction. In this case the deviation is 
significant, but it is in the wrong direction. In summary, 
the discriminant model based on the measures of health 
status failed to discriminate accurately between the
survivor and the deceased groups.
The demographic/medical variables were entered into a 
direct discriminant function analysis. The calibration 
sample consisted of 71 survivors and 12 deceased subjects. 
The standardized linear discriminant function coefficients 
developed on the calibration sample with .86 prior
probability of correct classification are presented in
Table 27. The resultant classification of subjects into
survivor and deceased groups is summarized in Table 28. In 
the calibration sample, 86? (71 from a total of 83) of the 
subjects were correctly classified and 14? (12 from a total 
of 83) of the subjects were incorrectly classified into 
survivor and deceased groups. As indicated in Table 28, 68 
subjects or 95.77? from the surviving sample were correctly 
classified as survivors, while 3 subjects or 4.23? from the 
surviving sample were incorrectly classified as deceased. 
In the deceased sample, 3 subjects or 25? were correctly 
classified as deceased, while 9 subjects or 75? from the 
deceased sample were incorrectly classified as surviving.
The holdout sample consisted of 41 survivors and 5 
deceased subjects, yielding a maximum chance criterion of
t
.89. The model was applied to the holdout sample, and the
resultant classification of subjects into survivor versus 
deceased groups is summarized in Table 29. As displayed, 
8956 (41 from a total of 46) of the subjects were correctly
classified, and 1156 (5 from a total of 46) of the subjects 
were incorrectly classified into survivor and deceased 
groups. Thus, the model based on the demographic/medical 
variables equalled the maximum chance criterion. That is, 
the model predicted as well as a chance criterion that
i
involved the placement of all subjects into the larger 
(survivor) group. As indicated in Table 29, 41 subjects or 
100/6 from the surviving group were correctly classified as 
survivors, while no subjects from the surviving sample were 
incorrectly classified as deceased. In the deceased
sample, no subjects were correctly classified as deceased, 
while 5 subjects or 100/6 of the deceased group were
incorrectly classified as surviving. Neither the 
Chi-Square test nor the Fisher Exact Probability Test could 
be used on this data to determine whether the two groups 
differed in the proportion falling into survivor and
deceased groups, because of the size of the cell
frequencies. Nonetheless, it can be readily observed that 
the model misclassified 100/6 of the deceased group. In
summary, the discriminant model based on the
demographic/medical variables also failed to discriminate 
accurately between the surviving and deceased groups.
A direct discriminant function analysis procedure was 
performed using the combined health status measures and the
demographic/medical variables as predictors of survival. 
The calibration sample contained 69 survivors and 12 
deceased subjects, yielding a prior probability of correct 
classification of .85. The resultant classification of 
subjects into survivor and deceased groups is summarized in 
Table 30. In the calibration sample, 100% (81 of a total of 
81) of the subjects were correctly classified and none (0 
from a total of 81) were incorrectly classified into 
survivor and deceased groups. As indicated in Table 30, 69 
subjects or 100%'of the surviving sample were correctly 
classified as survivors, while no subjects from the 
surviving sample were incorrectly classified as deceased. 
In the deceased group, 12 subjects or 100% of the deceased 
group were correctly classified as deceased, while no 
subjects from the deceased group were incorrectly 
classified as surviving.
The holdout sample consisted of 37 survivors and 5 
deceased subjects, yielding a maximum chance criterion of 
.88. The model was applied to the holdout sample, and the 
resultant classification of subjects into survivor versus 
deceased groups is summarized in Table 31. As displayed, 
88% (37 from a total of 42) of the subjects were correctly 
classified and 12% (5 from a total of 42) of the subjects
were incorrectly classified into survivor and deceased 
groups. Thus, the model based on the combined health 
status measures and demographic/medical variables only 
equalled the maximum chance criterion. As indicated in
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Table 31, 37 subjects or 100$ of the survivors were
correctly classified as survivors, while no subjects from 
the surviving sample were incorrectly classified as 
deceased. In the deceased group, no subjects were 
correctly classified as deceased, while 5 subjects or 100^ 
of the deceased group were incorrectly classified as 
surviving. Again, neither the Chi-Square Test nor the 
Fisher Exact Probability Test was appropriate for use with 
this data due to the size of the cell frequencies. But, as 
can be seen from Table 31, the model misclassified 10056 of 
the deceased group. Therefore, the model does not 
accurately predict survival from the combined measures of 
health status and the demographic/medical variables.
In summary, each of the three sets of predictor 
variables which included the measures of health status, the 
demographic/medical variables, and the combined health 
status measures and demographic/medical variables failed to 
discriminate accurately between the survivor and deceased 
groups.
Despite the failure of the measures of health status 
and the demographic/medical variables to discriminate 
significantly between survivor and deceased groups, group 
differences on these variables were assessed by means of a 
multivariate analysis of variance (MANOVA) and subsequent 
one-way analyses of variance (ANOVAs).
The means for the surviving and deceased groups, 
respectively, on the dependent measures of blood urea
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nitrogen, potassium, phosphorous, hematocrit, staff ratings 
of functional status, physician ratings of physical status, 
the Wahler Physical Symptoms Inventory, subjective ratings 
of functional status, subjective ratings of health, age, 
length of time on dialysis, and total number of concurrent 
diagnoses are presented in Table 32. Subsequent analyses 
also included the dummy coded variables of the diagnoses of 
diabetes mellitus and primary hypertension.
Multivariate analysis of variance revealed a highly 
significant effect, JP (14, 108) = 2.92, £ < .0009.
Subsequent one-way analyses of variance were performed, and 
the results are presented in Tables 33 - 46. Significant
group differences were in the anticipated direction; that 
is, surviving subjects appeared to be healthier than 
subjects who subsequently died during the study interval. 
Surviving subjects were initially rated as functioning at a 
higher level than the subjects who subsequently died during 
the study interval as indicated by both staff ratings of 
functional status, F(1, 121) = 26.64, £ < .0001, and
subjective ratings of functional status, F(1, 121) = 8.06, 
£ < .005. Further, physicians also viewed the surviving 
subjects as "healthier" or experiencing less severe medical 
complications than the subjects who subsequently died, F(1, 
121) = 7.29, £ < .008. Similarly, the groups differed on
scores on the Wahler Physical Symptoms Inventory. The 
subjects who subsequently died during the study interval 
endorsed a greater frequency of physical symptoms, F(1,
121) = 10.00, £ < .002. The deceased group was also found
to have been maintained on chronic hemodialysis for a 
significantly longer time, F(1, 121) =5.67, £ < .02, and to 
be suffering from a greater number of concurrent diagnoses 
in addition to chronic renal failure, F(1, 121) = 4.84, £ < 
.03, than the survivor group. Despite previous findings 
linking subjective ratings of health to mortality, no 
significant differences were found between the two groups 
on this measure. Additionally, no significant differences 
were found between the surviving and deceased groups on age 
or a diagnosis of diabetes mellitus or primary 
hypertension. Congruent with previous findings in this 
study, no significant differences were found between the 
two groups on any biochemical measure.
Chapter IV
Discussion
The present study was designed to assess the 
concurrent and predictive validity of a number of health 
status measures. As such, the interrelations among the 
measures of health status were examined, as well as the 
relation between the measures of health status and 
subsequent medical utilization and survival in a sample of 
hemodialysis patients. Overall, the present investigation 
offers evidence for the concurrent validity of physician 
ratings of physical status, ratings of functional status, 
and the Wahler Physical Symptoms Inventory as measures of 
the construct of health status. The data also confirm 
previous findings which suggest that physician ratings are 
the most valid measure of health status (Twaddle, 1974).
Significant intercorrelations were found among 
physician ratings of physical status, ratings of functional 
status, and the Wahler Physical Symptoms Inventory. 
Additional support for the validity of these measures of 
health status was provided by the significant relations 
found between these measures and other important health 
variables such as age, length of time on dialysis, 
diagnosis of diabetes mellitus, and total number of 




Interestingly, no significant relations were found 
between the biochemical measures of blood urea nitrogen, 
potassium, phosphorous, and hematocrit, and the remaining 
measures of health status. Further, the biochemical
measures showed little relation to other variables found in 
previous research to have a significant impact upon the
health of hemodialysis patients such as a diagnosis of 
diabetes mellitus (Hellerstedt, et al., 1984; Krakauer, et 
al., 1983). The data suggest that the biochemical measures 
used may have little relation to the construct of health 
status.
In the present sample, the biochemical measures of 
blood urea nitrogen, potassium, and phosphorous were 
moderately intercorrelated, however, hematocrit failed to 
correlate significantly with any other measure of health
status or demographic/medical variable. As noted 
previously, the biochemical measures of blood urea
nitrogen, potassium, and phosphorous are among the most 
commonly used measures of compliance in the hemodialysis
f
literature. It is not surprising to find significant
intercorrelations among various measures of compliance. 
Previous studies have suggested that compliance with one 
aspect of the dialysis medical regimen is predictive of 
compliance with the other components of the regimen as well 
(Cummings, et al., 1981).
Dietary restrictions and medication intake are viewed
as important aspects of the dialysis treatment regimen, and 
noncompliance with this regimen and the resultant changes 
in blood chemistries are assumed to have a direct impact
upon health status (Cummings, Becker, Kirscht, & Levin,
1981; Czaczkes & De-Nour, 1978). Seime (1980) pointed out 
the paucity of data related to compliance with the medical 
regimen and the daily functioning of dialysis patients, 
particularly with regard to feelings of well-being and 
physical symptoms. He proposed that noncompliance may have 
little relation to physical symptoms, yet have dire
long-term consequences reflected in increased morbidity 
and/or mortality. The results of the present study are in 
contrast to the notion that compliance is a critical 
variable influencing both physical functioning and 
survival. Specifically, the present research did not 
support Seime's observations. Not only did the biochemical 
measures fail to correlate significantly with the other 
measures of physical symptomatology and functional status, 
but the measures of compliance showed little relation to 
medical utilization as. well. Further, no significant
differences were found between the surviving and deceased 
groups on any biochemical measure.
Despite the commonly held view that the biochemical 
measures of blood urea nitrogen, potassium, and 
phosphorous, as well as hematocrit, reflect parameters 
critical to health status in dialysis patients, previous 
research has also failed to consistently link any one or
combination of these measures to longevity or survival 
(Armstrong & Woods, 1983; Farmer, et al., 1979; Foster & 
McKegney, 1978; Foster, et al., 1973; Richmond, Lindsay, 
Burton, Conley, & Wai, 1982; Wai, et al., 1981). In fact, 
previous research designed to examine this relation has 
produced inconsistent and conflicting results. For 
example, Wai and colleagues (1981) studied the influence of 
a number of physiological and psychological variables on 
the survival of 285 home dialysis patients. Included in 
the investigation were measures of blood urea nitrogen, 
potassium, phosphorous, as well as hematocrit. Hematocrit 
and total protein levels were found to significantly 
discriminate between survivors and nonsurvivors. However, 
other investigations have reported that the physiological 
indices of blood urea nitrogen, potassium, phosphorous, and 
hematocrit show no relation to survival in samples of 
in-center dialysis patients (Foster & McKegney, 1978; 
Foster, et al., 1973) and home dialysis patients (Richmond, 
et al., 1982).
Subjective ratings of health showed an inconsistent 
pattern of correlations with the other measures of health 
status and the demographic/medical variables in this 
sample. Although significant correlations were found among 
subjective ratings of health and physician ratings, the 
Wahler Physical Symptoms Inventory, and subjective ratings 
of functional status, no significant relation was found 
between this measure of health status and staff ratings of
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functional status or any biochemical measure. 
Additionally, subjective ratings of health failed to 
significantly correlate with any demographic/medical 
variable assessed in this study. Further, no significant 
differences were found between survivor and deceased groups 
on this measure. These findings are in contrast to recent 
longitudinal studies which suggest that subjective ratings 
of health may be one of the best single indicators of 
health status. This measure has been linked to mortality 
in extensive longitudinal studies conducted on an elderly 
sample (Mossey & Shapiro, 1982) and a representative 
community sample (Kaplan & Camacho, 1983).
Denial has been repeatedly implicated as a primary 
coping strategy employed by hemodialysis patients in their 
adjustment to chronic maintenance dialysis (Short & Wilson, 
1969; Yanagida, Streltzer, & Siemsen, 19 81 ). It is not 
surprising to find dialysis patients having difficulty in 
accurately assessing and rating their own health status, 
because of their strong tendency to deny problems and 
present themselves in a socially desirable manner 
(Strauch-Rahauser, Schafheutle, Lipke, & Strauch, 1977; 
Yanagida & Streltzer, 1979). The rating scale used in the 
present study may have been particularly problematic,
because dialysis patients were asked to rate their health
in terras of the following adjectives: excellent, good,
fair, and poor. The other subjective rating scale
completed by subjects in this study consisted of a rating
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of functional status. This rating scale did not appear to 
present difficulties in accurate completion, probably 
because the scale offers extensive behavioral descriptors 
of each scale interval. The current data would support the 
suggestions of other researchers in the cautious use of 
subjective assessment devices with hemodialysis patients 
(Yanagida & Streltzer, 1979). Further, the present data 
offers little evidence for the validity of subjective 
ratings of health when used as an index of health status in 
hemodialysis patients.
The purpose of the present study was also to examine 
the predictive validity of the measures of health status. 
Physician ratings of physical status were found to be the 
best predictor of medical utilization in this sample.
Physicians have been termed the ultimate health status
definers due to their training and expertise (Twaddle, 
1974). For this reason, physician ratings are frequently
the criterion against which other measures of health status 
are compared (De-Nour & Czaczkes, 1974; Steidl, et al., 
1980). Nonetheless, previous investigations have generally 
failed to validate physician ratings against appropriate 
criteria such as medical utilization.
These results are important in terms of the 
application of the measures of health status both 
clinically and in research. Evidence for the validity of 
physician ratings allows rational choices to be made among 
the available measures of health status. Physician ratings
104
appear to be the best single measure of health status in 
hemodialysis patients. As such, this measure can be useful 
in assessing the efficacy of interventions designed to 
impact upon the health status of these patients, as well as 
in examining the relation between psychological factors and 
lifestyle variables on chronic renal disease.
Despite strong recommendations in the past for the use 
of physician ratings in the assessment of health in 
research, physician ratings or the medical examination have 
been used only infrequently due to practical considerations 
such as cost (Cleary, 1980). Hemodialysis centers generally 
have staff physicians or nephrologists who are familiar 
with each patient's medical status as a result of a high 
degree of on-going medical supervision. Consequently, 
physician ratings of dialysis patients can be completed 
with a minimum of time expenditure, making the routine use 
of this measure of health status feasible.
Research is needed to further explore the psychometric 
properties of this measure. At the time of the present 
investigation, data were not available regarding the 
test-retest reliability of the physician rating scale used 
in this study. Also, the level of agreement achieved (.73) 
between the two physicians in this study on the rating 
scale was only moderate. Research is continuing that was 
designed to assess the test-retest reliability of this 
measure. Additionally, the utility of physician training 
in the use of explicitly defined behavioral anchors for the
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rating scale is being examined in an effort to improve 
interrater reliability. Additional research is also needed 
to examine the sensitivity of the physician rating scale to 
changes in health status. A line of investigation that 
warrants further study involves the delineation of the 
components of physical status in dialysis patients that 
comprise physician global ratings. No single clinical or 
biochemical measure has proven to be acceptable in defining 
proper or adequate dialysis treatment. However, it is 
likely that physicians evaluate and differentially weight a 
vast amount of information that includes a number of health 
indices such as biochemical measures or physical symptoms 
in arriving at a single global rating of physical status. 
Information related to the components involved in physician 
ratings of physical status would have implications relevant 
to the development of more sensitive measures of health 
status in dialysis patients.
Although physician ratings of physical status were 
found to be the best predictor of medical utilization, the 
predictive validity of this measure and the other indices
t
of health status examined in the present investigation are 
of concern. Despite statistical significance, the measures 
of health status accounted for a surprisingly small amount 
of the variance in medical utilization. Further, even 
though statistically significant differences were found 
between survivor and deceased groups on the measures of 
physician ratings, ratings of functional status, and the
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Wahler Physical Symptoms Inventory, not enough of the 
variance was accounted for by these measures for them to be 
predictive of survival. These findings may be due to 
limitations inherent in the measures of health status 
examined in the present study and/or limitations in the 
methodology employed.
Because reliability has strong implications for the 
validity of a measure, the reliability of the measures used 
in this investigation warrant further study. Specifically, 
a factor which may limit the conclusions that may be drawn 
from the data involves the questionable reliability or 
stability of the biochemical measures of blood urea 
nitrogen, potassium, phosphorous, and hematocrit. Although 
previous research would suggest stability in the 
biochemical measures (De-Nour & Czaczkes, 1976; Seime, 
1980), no study to date has directly assessed the 
reliability of these measures in dialysis patients.
Previous investigations have utilized various sampling 
procedures ranging from one (Wai, et al., 1981 ) to multiple 
(Cummings, et al. , 1984; Foster, et al., 1973)
observations, where the mean of the observations is used 
for analyses. Only a single observation of each 
biochemical measure was used in the present investigation. 
It is possible that a different pattern of correlations 
might have emerged had multiple measures been obtained and 
the mean of these measures used for analyses. However, the 
inconsistency in sampling procedures found across previous
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studies may also account for the disparate findings 
reported regarding the relation of biochemical measures to 
morbidity and mortality.
Additional research is needed to assess the 
reliability or stability of the biochemical measures of 
blood urea nitrogen, potassium, phosphorous, and hematocrit 
in dialysis patients. In this way, the degree of 
variability in these measures will be assessed, and a 
uniform sampling procedure can be proposed which will have 
implications for the compliance literature as a whole. A 
uniform measurement technique will then allow comparisons 
to be made across studies. Also, before concluding that 
compliance with the treatment regimen has no relation to 
health status in hemodialysis patients, further research is 
needed to examine the relation of compliance to other 
indices of physical functioning such as physical symptoms 
and functional status, as well as its relation to important 
health outcomes such as morbidity or mortality.
Also as mentioned previously, data were not available 
regarding the test-retest reliability of physician ratings 
of physical status or ratings of functional status. 
Further research is needed to address the stability of 
these measures.
Given the chronically ill status of the present 
sample, the possibility of a restricted range of responses 
on the measures of health status was examined. However, 
the measures of health status revealed considerable
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variability among subjects, suggesting that the lack of 
association was not a restriction of range problem.
A potential limitation of the study involves the 
length of the study interval. One year may be too short to 
provide meaningful information regarding the criterion 
variables of medical utilization and survival in this 
sample. Researchers involved in the assessment of factors 
thought to impact upon medical utilization such as drug, 
alcohol or mental health interventions generally stress 
that one year is the absolute minimum needed to assess 
meaningful trends in the use of health care services (Jones 
& Vischi, 1979; Longobardi, 19 81). The time interval 
frequently recommended to discern trends in health care 
utilization is up to five years. The problem of the length 
of the study interval is also reflected in the small size 
of the deceased group at the end of only one year. The 
small size of this group presented difficulties in 
statistical analyses. Consequently, the results of the 
discriminant analyses are viewed as less stable. It may be 
that more meaningful data related to the predictive 
validity of these measures may be gained by extending the 
length of the investigation and continuing data 
collection. For this reason, it is recommended that these 
data be reanalyzed at the end of two years.
The predictive validity of the demographic/medical 
variables also examined in this study warrant further 
comment. The demographic/medical variables included age,
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length of time on dialysis, diagnosis of diabetes mellitus, 
diagnosis of primary hypertension, and total number of 
concurrent diagnoses present in addition to chronic renal 
failure. Similar to the measures of health status, these 
variables significantly predicted medical utilization. 
However, although statistical significance was reached, 
only a small amount of the total variance was accounted for 
by these variables. More importantly, the
demographic/medical variables failed to accurately predict 
survival in this sample, despite statistically significant 
differences that were found between survivor and deceased 
groups on length of time on dialysis and total number of 
concurrent diagnoses. These results appear to be in 
contrast to previous large-scale research which 
consistently link such demographic/medical variables to 
survival in hemodialysis patients (Hellerstedt, et al., 
1984; Krakauer, et al., 1983). Two additional factors may 
account for such disparate findings, and include the design 
of the present study and the nature of the sample.
The current study utilized a cross-sectional design in 
which all available hemodialysis patients served as 
subjects. The participating subjects were then followed 
over the course of one year, during which time medical 
utilization and survival for the sample were assessed. In 
the present study, demographic and medical information was 
obtained for each subject at the time of the initial 
assessment phase of the investigation. Previous studies
which have examined similar variables as predictors of
survival in hemodialysis patients are longitudinal in 
design. In these studies, demographic/medical variables 
are assessed at the time of initiation of dialysis 
treatment. For example, age in the present study meant age 
of the subject at the time of the initial assessment phase 
of the investigation. However, in the data reviewed by 
Krakauer and colleagues (1983) on the U. S. dialysis 
population, the variable of age represented age when the 
patient initially began dialysis treatment. It is possible 
that a diagnosis of diabetes mellitus at the time of
initiation of dialysis versus at a later point in 
hemodialysis treatment may have differing levels of impact 
upon survival. Also the length of the study interval in
the present investigation is considerably shorter than 
previous large-scale longitudinal studies.
As noted previously, the present sample was
predominantly black (71/6), unemployed (84/6), and of lower 
socioeconomic status. Additionally, 55/6 of the sample did
not complete high school. In this respect, the sample was 
not representative of the hemodialysis population in the
United States. For example, Krakauer, et al. (1983)
reported 17,194 blacks as compared with 43,990 whites 
nation-wide receiving maintenance dialysis. It is possible 
that other demographic/medical variables not assessed in
this study may be more critical to survival in this 
particular sample.
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In summary, this study is viewed as an initial attempt 
to examine the validity of a number of health status 
measures in a chronically ill population. The results of 
this investigation provide empirical data related to the 
strengths and weaknesses of the available measures of 
health status with hemodialysis patients. As such, the 
results provide for potential avenues of future research.
Evidence is presented for the concurrent validity of 
physician ratings of physical status, ratings of functional 
status, and the Wahler Physical Symptoms Inventory as 
measures of the construct of health status. Data also 
revealed that physician ratings were the best predictor of 
subsequent medical utilization in this sample. Although 
results suggest that physician ratings of physical status 
are the most valid measure of health status for use with 
hemodialysis patients, clinicians and researchers should be 
cautious in the application of these findings. While a 
potentially useful measure, further research establishing 
the reliability and validity of the physician rating scale 
is needed. Future research should also investigate the 
psychometric properties of the other measures of health 
status, and expand this work with other chronic illness 
groups to determine the generalizability of these 
findings.
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Survival Rates for Patients Receiving Dialysis or Undergoing Transplantation
DIALYSIS TRANSPLANTATION
UNRELATED DONOR RELATED DONOR
Survival Survival No. of Survival Survival No. of Survival Survival No. of
to 1 Year to 3 Years Cases to 1 Year to 3 Years Cases to 1 Year to 3 Years Cases
Total 81*0.2$ 56*0.3$ 65,270 86*0.4$ 78*0.5$ 7,595 95*0.4$ 91*0.6$ 3,491
Sex
Male 81*0.3 55*0.4 36,600 86*0.6 77*1.0 4,818 95*0.5 90*1.0 2,C79
Female 82*0.4 58*0.4 28,581 86*1.0 78*1.0 2,777 94*0.6 91*1.0 1,410
Total 65,181 7,595 3,489
Race
Black 85*0.3 62*0.6 17,194 86*1.0 78*1.0 1,625 93*1.0 87*2.0 364
White 80*0.2 54*0.3 43,990 86*0.5 77*1.0 5,588 95*0.4 91*1.0 2,905
Total 61,184 7,213 3,269
Age (yr)
<10 90*2.0 82*3.0 601 89*3-0 80*3.0 155 93*2.0 89*3-0 150
11-20 95*0.5 88*2.0 2,620 92*1.0 87*1.0 844 97*1.0 95*1.0 662
21-30 91*0.5 78*1.0 6,240 92*1.0 87*1.0 1,792 97*1.0 95*1.0 1,080
31-40 89*0.5 71*1.0 7,883 85*1.0 78*1.0 2,016 93*1.0 89*1.0 796
41-50 88*0.4 68*0.7 9,995 81*1.0 70*1.0 1,737 91*1.0 82*2.0 490
>50 77*0.2 48*0.3 35,991 79*1.0 68*2.0 1,051 88*2.0 81*3.0 208
Total 63,250 7,595 3,488
Primary disease
Primary hypertension 82*0.5 56*1.0 7,049 85*1.0 77*2.0 593 93*2.0 86*3.0 159
Glaaerulonephritis 91*0.5 69*1.0 6,538 87*1.0 81*1.0 1,760 97*1.0 93*1.0 811
Diabetic nephropathy 75*1.0 39*1.0 5,856 79*2.0 65*2.0 518 89*2.0 82*3.0 268
Polycystic kidneys 95*1-0 78*2.0 1,973 81*2.0 77*3-0 293 91*3-0 82*4.0 75
(Reprinted from Krakauer, Grauman, McMullan, and Creede, 1983, p. 1560)
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Table 2
Summary of Sample Characteristics













Lives alone 19 14.3












Means and Standard Deviations of Health Status Measures
Measure M SD
Biochemical Analyses Normal Values
Blood urea nitrogen (BUN) 76.73 20. 43 10.0-26.0 mg/dl
Potassium 5. 11 • 78 3-5- 5.0 mg/dl
Phosphorous 6.41 2.05 2.5- 4.2 mg/dl
Hematocrit 25.90 5.07 38.0-52.0 %
Physician Ratings 3-95 . 1.29
Staff Ratings 
of Functional Status 2.00 • 93
Wahler Physical 
Symptoms Inventory 1.37 .68
Subjective Ratings 
of Health 2. 84 .86
Subjective Ratings 
of Functional Status 2.53 .96
Table 4
Correlations Among Measures of Health Status and p Values (N =131)
















































































Wahler Physical .41* .53*






* £ <.001 u>00
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Table 5
Means, Standard Deviations, Frequencies, and 
Percentages of Demographic/Medical Variables
Variable
Age
Length of Time on 
Dialysis (in months)





































Correlations Among Measures of Health Status and Demographlc/Hedlcal 






















K P Hct PR
H6* . H7* -.03 -. 12
0001 .0001 . 7H . 17












. 9H . HH .30
-.05 -.002 -. 16
.60 .98 .08














» £ < .0005
SFS Age MOD DM PHT TDX
. 18 -.20 . 15 -.06 -.03 -.09
.OH .02 . 10 .53 .75 • 31
.007 -. 10 .07 .03 -.08 -.00H
.9H .28 . H6 .73 .35 .96
.11 -. 19 .09 .OH -.06 .06
.20 .03 • 3H .69 . H8 .50
.05 . 18 .23 -.06 -.13 —  02
.55 .05 .01 . H9 .13 .80
.58* .29 -.09 . 3H* -. 11 .HH'*
.0001 .001 • 3H .0001 .21 .0001
.68* . H9* -.06 .27 -. OOH .39*
.0001 .0001 .52 .002 .96 .0001
.53* .09 .02 .21 -.06 .37*
.0001 • 30 .8H .02 .52 .0001
. H3* .02 -.02 . 10 -.07 .21
.0001 .81 .81 . 2H . H3 .02
.38* -. 18 .31* .005 .37*
.0001 .05 .0003 .95 .0001
.001 .07 .02 . 3H*
• 99 .HO .86 .0001
-.23 -.09 .03
.01 .29 .70







Means, Standard Deviations, Frequency, and Percentage 
of Hospitalizations, Hospital Days, and Mortality
Variable Mean Standard Deviation
Number of Hospitalizations 1.2 1.4





Correlations Among Measures of Health Status, 








Blood Urea Nitrogen .11 .05 - .01
Potassium . 12 - .04 - .07
Phosphorous .24 . 11 .05
Hematocrit - .01 .0008 .04
Physician Ratings .28 .25 .23
Staff Ratings of 
Functional Status
. 16 .21 .40
Wahler Physical Symptoms .25 .22 C\1•
Subjective Health Status .23 .19 . 18
Subjective Functional 
Status
• 13 . 14 .24
Age - .02 .08 . 14
Months on Dialysis .20 .23 .21
Diabetes Mellitus - .003 - .07 .09







Number of Hospital Days .73 1.00 .49
Survival .48 .49 1.00
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Table 9
Multiple Regression Summary Table for Measures of 
Health Status and Number of Hospitalizations






























. 33 02 
-.2099
Subjective Ratings of Health . 3072
Table 10
Stepwise Multiple Regression for the Measures of Health Status 








df F £ Beta
Weight
1 Physician Rating • o CD 1, 123 10.62 <.001 .3097
2 Phosphorous . 12 2, 122 8.24 <.0004 .1759
3 Subjective 
Rating of Health
. 14 3, 121 6.37 <.0006 .2943
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Table 11
Multiple Regression Summary Table for the Demographic/Medical 
Variables and Number of Hospitalizations
Source df Sura of Squares
2
Mean Square F £ R
Model 5 39.64 7-93 2.73 .02 .10




Months on Dialysis .0082
Diabetes - .4893
Hypertension - .2237




Stepwise Multiple Regression for the Demographic/Medical 
Variables and the Number of Hospitalizations
Step Variable MultipleO df F £ Beta
Number Entered R Weight
1 Total Number of 
Concurrent Diagnoses
.04 1, 127 5.34 <.02 .3854
2 Months on Dialysis .08 2, 126 on•LfN <.006 .0100





Multiple Regression Summary Table for the Combined Measures 
of Health Status and Demographics/Medical Variables and the 
Number of Hospitalizations
2
Source df Sum of Squares Mean Square F £ R
Model 14 81.04 5.79 2.023 <-02 .21








Staff Functional Ratings .0249
Physician Ratings .3406
Subjective Ratings of .0183
Functional Status
Subjective Ratings of Health .1874
Age -.0133






Stepwise Multiple Regression for the Combined Measures of 









df F £ Beta
Weight
1 Physician Rating .07 1, 121 9.66 <.002 • 3315
2 Months on Dialysis . 13 2, 120 8.70 <.0003 .0113
3 Phosphorous . 16 3, 119 7.56 <.0001 . 1580
4 Subjective Health . 17 4, 118 6.21 <.0001 .2598
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Table 15
Multiple Regression Summary Table for Measures of
Health Status and Number of Hospital Days (Outliers Included)
Source df Sum of Squares
2
Mean Square F £ R
Model 9 11807.30 1311.92 1.56 .14 .11








Staff Functional Ratings 4.0182
Physician Ratings 4.0085
Subjective Ratings of 
Functional Status
-3.7148
Subjective Ratings of Health 3.7317
Table 16 
Multiple Regression Summary Table for the Demographic/Medical
Variables and Number of Hospital Days (Outliers Included)
Source df Sum of Squares Mean Square F
2
£ R
Model 5 6988.31 1397-66 1.75 o•onr—•




Months on Dialysis .1747
Diabetes -6.3364
Hypertension 1 .2931





Multiple Regression Summary Table for the Combined Measures
of Health Status and Demographic/Medical Variables and
Number of Hospital Days (Outliers Included)
Source df Sum of Squares Mean Square F
2
£ R
Model 14 20692.84 1478.06 1.91 .03 .20








Staff Functional Ratings 2.6556
Physician Ratings 5.9270
Subjective Ratings of 
Functional Status
.6712
Subjective Ratings of Health 2.2188
Age .0233
Months on Dialysis .2132
Diabetes -12.4591
Hypertension 2.4021




Stepwise Multiple Regression for the Combined Measures of 
Health Status and Demographic/Medical Variables and the 




df F £ Beta
Weight
1 Physician Rating .07 1, 121 8.67 <.004 8.0431
2 Months on Dialysis .14 2, 120 9.63 <.0001 .2011
3 Diabetes .17 3, 119 8.25 <.0001 13.9312
153
Table 19
Multiple Regression Summary Table for Measures of
Health Status and Number of Hospital Days (Outliers Excluded)

















Staff Functional Ratings 1.5549
Physician Ratings 2.8234
Subjective Ratings of 
Functional Status
-4.5506
Subjective Ratings of Health 4.0340
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Table 20
Multiple Regression Summary Table for the Demographic/Medical 
Variables and Number of Hospital Days (Outliers Excluded)
Source df Sum of Squares
2
Mean Square F £ R
Model 5 7129.47 1425.89 4.40 .001 .15




Months on Dialysis . 1536
Diabetes 5.9283
Hypertension 3.6623




Stepwise Multiple Regression for the Demographic/Medical 






df F £ Beta
Weight
1 Months on Dialysis . 10 1, 125 14.18 .0003 . 1613
2 Total Number of 
Concurrent Diagnoses
. 13 2, 124 9.34 .0002 3-9829
3 Diabetes . 14 3, 123 6.72 .0004 5.0707
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Table 22
Multiple Regression Summary Table for the Combined Measures 
of Health Status and Demographic/Medical Variables and the 
Number of Hospital Days (Outliers Excluded)
2
Source df Sum of Squares Mean Square F £ R
Model 14 10832.11 773-72 2.390 .006 .24








Staff Functional Ratings 1.5174
Physician Ratings 2.6654
Subjective Ratings of - .7869
Functional Status
Subjective Ratings of Health 1.8459
Age .1118






Stepwise Multiple Regression for the Combined Measures of 
Health Status and Demographic/Medical Variables and the 






df F 2 Beta
Weight
1 Months on Dialysis . 12 1, 119 15.69 .0001 . 1925
2 Physician Rating . 16 2, 118 11.11 .0001 3.4403




Standardized Linear Discriminant Function (LDF) 
Coefficients for the Health Status Measures
Variable LDF Coefficients
Survivors Deceased
Blood Urea Nitrogen .0287 .0397
Potassium 8.8153 8.3276
Phosphorous .0329 . 1574
Hematocrit 1.2664 1.3662
Wahler Physical Symptoms Inventory .3868 .4686
Staff Ratings of Functional Status 3.0363 4.6752
Physicians Ratings 1.3063 .7578
Subjective Health Status 4.8907 5.3164
Subjective Functional Status -1.5661 -1 .8728
Table 25
Discriminant Analysis Classification for the










Survivors 67 97.10 2 2.90 69
Deceased 10 76.92 3 23.08 13
Total 77 93.90 5 6.10 82
a
prior probability = .84
Table 26
Discriminant Analysis Classification for the










Survivors 37 97.37 1 2.63 38
Deceased 3 60.00 2 40.00 5
Total 40 93.02 3 6.98 43
a
prior probability = .88
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Table 27
Standardized Linear Discriminant Function (LDF) 




Months on Dialysis .0416 .0669
Diabetes 1.5097 2.2032
Hypertension 2.7862 2.7429
Total Number of Concurrent Diagnoses .3473 .8618
Table 28
Discriminant Analysis Classification for the










Survivors 68 95.77 3 4.23 71
Deceased 9 75.00 3 25.00 12
Total 77 92.77 6 7.23 83
a
prior probability = .86
Table 29
Discriminant Analysis Classification for the










Survivors 41 100.00 0 0.00 41
Deceased 5 100.00 0 0.00 5
Total 46 100.00 0 0.00 46
a
prior probability = .89
Table 30
Discriminant Analysis Classification for the











Survivors 69 100.00 0 0.00 69
Deceased 0 0.00 12 100.00 12
Total 69 85. 19 12 14.81 81
a
prior probability = .85
Table 31
Discriminant Analysis Classification for the











Survivors 37 100.00 0 0.00 37
Deceased 5 100.00 0 0.00 5
Total 42 100.00 0 0.00 42
a
prior probability = .88
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Table 32





Blood Urea Nitrogen 76.67 75.59
Potassium 5. 10 4.95
Phosphorous 6. 32 6.66
Hematocrit 25.75 26.35
Staff Ratings of Functional Status 1.83 2.97
Physicians Ratings 3.79 4.68
Wahler Physical Symptoms Inventory 1.28 1.82
Subjective Functional Status 2.42 3. 12
Subjective Health Status 2.77 3.18
Age 51.26 57.35
Months on Dialysis 36.44 57.24




Analysis of Variance Summary Table 
for Blood Urea Nitrogen (BUNT
Source df Sum of Squares Mean Square F E
2
R
Model 1 17-14 17. 14 .04 .84 .0003




Analysis of Variance Summary Table 
for Potassium
Source df Sum of Squares Mean Square F £
2
R
Model 1 .31 • 31 • 53 .47 .004




Analysis of Variance Summary Table 
for Phosphorous
Source df Sum of Squares Mean Square F
2
£ R
Model 1 1.70 1.70 .41 .52 .003




Analysis of Variance Summary Table 
for Hematocrit
Source df Sum of Squares Mean Square F £
2
R
Model 1 5.24 5.24 .20 .65 .002




Analysis of Variance Summary Table 
for Staff Ratings of Functional Status
-
Source df Sum of Squares Mean Square F £ R
Model 1 19-21 19.21 26.64 .0001 .18




Analysis of Variance Summary Table 
for Physician Ratings of Physical Status
Source df Sum of Squares Mean Square F
2
£ R
Model 1 11.45 11.45 7.29 .008 .06




Analysis of Variance Summary Table 
for Wahler Physical Symptoms Inventory
Source df Sum of Squares Mean Square F £
2
R
Model 1 4.25 4.25 10.00 .002 00o




Analysis of Variance Summary Table
for Sub.jective Ratings of Functional Status
2
Source df Sum of Squares Mean Square £  £ R
Model 1 7.04 7.04 8.06 .005 .06




Analysis of Variance Summary Table 
for Sub.jective Ratings of Health
; 2
Source df Sum of Squares Mean Square F £ R
Model 1 2.38 2.38 3-38 .07 .03




Analysis of Variance Summary Table
for Age
2
Source df Sum of Squares Mean Square F £ R
Model 1 543. 14 543.14 2.74 . 10 .02




Analysis of Variance Summary Table 
for Number of Months on Dialysis
Source df Sum of Squares Mean Square F £
2
R
Model 1 6333.41 6333.41 5.67 .02 .04




Analysis of Variance Summary Table 
for Total Number of Concurrent Diagnoses
Source df Sum of Squares Mean Square F L
2
R
Model 1 5.29 5.29 4.84 .03 .04





Analysis of Variance Summary Table 
for Diabetes Mellitus
Source df Sum of Squares Mean Square F £
2
R
Model 1 • 09 .09 .49 .49 .004




Analysis of Variance Summary Table 
for Primary Hypertension
, _ 
Source df Sum of Squares Mean Square I! £ R
Model 1 .04 .04 .15 .70 .001






Please estimate each patient's current medical 
condition on the attached sheet. Please indicate the 
number of the scale item contained below which best 
describes the patient’s overall physical status:
1. Patient is largely free of medical problems and is







7. Patient is suffering from and is incapacitated by




WAHLER PHYSICAL SYMPTOMS INVENTORY
Name ___________________  Age   Sex: M F Date________
WHAT YOU ARE TO DO:
Below is a list of physical troubles. Please indicate 
how often each of these bothers you. Do this by circling 
the number to the right of each trouble which shows how 
often you are bothered by that trouble. Keep in mind that 
the LARGER the number the MORE OFTEN the trouble bothers 
you. Please DO NOT SKIP any troubles. You may take as 
much time as is necessary.
Nearly every day -------II
About twice a week ---- i
■ i
About once a week   I I
i i i
About once a month —  ! ! !
i i i i
i i i i
About once a year —  ! ! ! I
Almost never ------ii
1. Nausea (Feeling like 
throwing up). 0 2 3 4 5
2. Headaches. 0 2 3 4 5
3. Trouble with ears or hearing. 0 2 3 4 54. Neck aches or pains. 0 2 3 4 5
5. Feeling hot or cold regardless 
of the weather. 0 2 3 4 5
6. Arm or leg aches or pains. 0 2 3 4 5
7. Shakiness. 0 2 3 4 5
8. Swelling of arms, hands, 
legs, or feet. 0 2 3 4 5
9. Stuttering or stammering. 0 2 3 4 5
10. Difficulty sleeping. 0 2 3 4 5
11. Losing weight. 0 2 3 4 5
12. Backaches. 0 2 3 4 5
13. Intestinal or stomach trouble. 0 2 3 4 514. Difficulty with urination 
(Passing water). 0 2 3 4 5
15. Heart trouble. 0 2 3 4 516. Trouble with teeth. 0 2 3 4 5
17. Numbness, or lack of feeling 
in any part of the body. 0 2 3 4 518. Aches or pains in hands or feet. 0 2 3 4 5
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Nearly every day 
About twice a week
About once a week ----
About once a month ---II
About once a year --- I
i ii i
Almost never -------  ! i
19. Fainting spells. 0 1 2 3 4 5
20. Excessive perspiration. 0 1 2 3 4 5
21. Abnormal blood pressure. 0 1 2 3 4 5
22. Paralysis (Unable to move 
parts of the body). 0 1 2 3 4 5
23. Trouble with eyes or vision. 0 1 2 3 4 5
24. Burning, tingling, crawling 
feelings in the skin. 0 1 2 3 4 5
25. Skin trouble (Rashes, boils 
or itching). 0 1 2 3 4 5
26. Feeling tired. 0 1 2 3 4 5
27. Muscular weakness. 0 1 2 3 4 5
28. Dizzy spells. 0 1 2 3 4 5
29. Muscular tensions. 0 1 2 3 4 530. Any trouble with the senses 
of taste or smell. 0 1 2 3 4 5
31. Difficulty breathing (Short of breath, asthma, etc.). 0 1 2 3 4 5
32. Twitching muscles. 0 1 2 3 4 5
33. Poor health in general. 0 1 2 3 4 534. Excessive gas. 0 1 2 3 4 5
35. Difficulty swallowing. 0 1 2 3 4 5
36. Seizures. 0 1 2 3 4 5
37. Gaining weight. 0 1 2 3 4 5
38. Difficulty with appetite. 0 1 2 3 4 5
39. Bowel trouble (Constipation 
or loose bowels). 0 1 2 3 4 5
40. Vomiting. 0 1 2 3 4 5
41. Chest pains. 0 1 2 3 4 5
42. Hay fever or other allergies. 0 1 2 3 4 5
Please write down any important physical symptoms not





(patient's name) current general level of physical 
activity. Please circle the number of the scale item which 
best describes the patient's current functional status or 
degree of disability:
1. Capable of performing all usual types of physical
activity
2. Unable to perform the most strenuous of usual physical
activities (e.g. sports, fast walking, shoveling snow, 
lawn mowing)
3. Unable to perform usual daily activities on more than 
a part-time basis (e.g. housework, employment, driving 
a car, playing with children)
4. Severe limitation of usual physical activity, may need
assistance with some aspects of self care, may have




Please estimate your current level of physical 
activity. Please circle the number of the scale item which 
best describes your current functional status or degree of 
disability:
1. Capable of performing all usual types of physical 
activity
2. Unable to perform the most strenuous of usual physical 
activities (e.g. sports, fast walking, shoveling snow, 
lawn mowing)
3. Unable to perform usual daily activities on more than 
a part-time basis (e.g. housework, employment, driving 
a car, playing with children)
4. Severe limitation of usual physical activity, may need 
assistance with some aspects of self care, may have 
impaired mentation, may be confined to bed
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APPENDIX E
SUBJECTIVE RATING OF HEALTH
Please estimate, in your own opinion, your current 
level of health. Circle the number of the scale item which 









I, ______________________________________, freely and
willingly consent to be a participant in a research project 
investigating the assessment of health status in 
hemodialysis patients. This project is being directed by 
P. J. Brantley, Ph.D., T. B. Cocke, M.D., and G. T. 
McKnight, M.D., of the LSU Medical School.
As a research subject, I agree to participate in one 
assessment interview lasting 20 minutes, in which I will be 
asked to answer several paper and pencil questionnaires. 
Additionally, I agree to allow the research team to review 
any of my pertinent medical records. I understand that 
there are no risks involved by participation in this 
project.
I understand that I may withdraw from participation in 
this study at any time with no adverse consequences. In 
addition, any information I provide during this project 
will be kept in strict confidence, and if this information 
is presented publicly (i.e. conferences, journal articles), 
no information will be identified with me personally.
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I realize that I have a right to ask questions at any 
time and to have these questions answered to my 







Patient’s Name ________________________  ID# _________________
Age _______ Sex   Race/Ethnic ____________________
Occupation/Vocation   Current job status __________
Marital Status ____  How long? ____  Age of partner ___
Education: Gr   Hs   Coll_____  Grad S ____
Source(s) of income ____________________________________________
Living arrangements ____________________________________________




Drug Home/Unit Dose Administration Regimen
Current Dialysis:
_______ hrs. per visit Date dialysis began
Relevant treatment history ________________________
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